GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Wrnip1
|
ENSRNOG00000017040 | Werner helicase interacting protein 1 |
Mta3
|
ENSRNOG00000004685 | metastasis associated 1 family, member 3 |
Rcor1
|
ENSRNOG00000008067 | REST corepressor 1 |
Rcor1
|
ENSRNOG00000049783 | REST corepressor 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Wrnip1 | rn6_v1_chr17_-_32953641_32953641 | 0.53 | 2.9e-24 | Click! |
Rcor1 | rn6_v1_chr6_+_135513650_135513650 | -0.33 | 1.4e-09 | Click! |
Mta3 | rn6_v1_chr6_+_6908684_6908684 | -0.14 | 1.1e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_10766253 | 168.14 |
ENSRNOT00000000117
|
Cplx2
|
complexin 2 |
chr6_-_99870024 | 164.80 |
ENSRNOT00000010043
|
Rab15
|
RAB15, member RAS oncogene family |
chr20_+_10123651 | 148.72 |
ENSRNOT00000001559
|
Pde9a
|
phosphodiesterase 9A |
chr9_-_94601852 | 148.62 |
ENSRNOT00000022485
|
Ngef
|
neuronal guanine nucleotide exchange factor |
chr3_-_176666282 | 147.06 |
ENSRNOT00000016947
|
Eef1a2
|
eukaryotic translation elongation factor 1 alpha 2 |
chr6_+_105364668 | 143.84 |
ENSRNOT00000009513
ENSRNOT00000087090 |
Ttc9
|
tetratricopeptide repeat domain 9 |
chr3_+_6773813 | 130.81 |
ENSRNOT00000065953
ENSRNOT00000013443 |
Olfm1
|
olfactomedin 1 |
chr1_+_101682172 | 128.22 |
ENSRNOT00000028540
|
Car11
|
carbonic anhydrase 11 |
chr13_-_52197205 | 126.27 |
ENSRNOT00000009712
|
Shisa4
|
shisa family member 4 |
chr13_+_104816371 | 120.42 |
ENSRNOT00000086497
|
AABR07022057.1
|
|
chr10_+_15088935 | 118.00 |
ENSRNOT00000030273
|
Gng13
|
G protein subunit gamma 13 |
chrX_+_39711201 | 113.96 |
ENSRNOT00000080512
ENSRNOT00000009802 |
Cnksr2
|
connector enhancer of kinase suppressor of Ras 2 |
chr10_+_72272248 | 113.94 |
ENSRNOT00000003908
|
Car4
|
carbonic anhydrase 4 |
chr1_-_189960073 | 113.84 |
ENSRNOT00000088482
|
Crym
|
crystallin, mu |
chr20_+_5535432 | 108.24 |
ENSRNOT00000040859
|
Syngap1
|
synaptic Ras GTPase activating protein 1 |
chr18_-_17716880 | 106.72 |
ENSRNOT00000061151
|
Celf4
|
CUGBP, Elav-like family member 4 |
chr12_+_31530699 | 106.40 |
ENSRNOT00000033379
ENSRNOT00000067867 |
Rimbp2
|
RIMS binding protein 2 |
chr4_-_52350624 | 106.00 |
ENSRNOT00000060476
|
Tmem229a
|
transmembrane protein 229A |
chr8_-_130127392 | 105.27 |
ENSRNOT00000026159
|
Cck
|
cholecystokinin |
chr8_-_58542844 | 105.22 |
ENSRNOT00000012041
|
Elmod1
|
ELMO domain containing 1 |
chr8_+_111600532 | 104.48 |
ENSRNOT00000081952
|
Rab6b
|
RAB6B, member RAS oncogene family |
chr19_-_9801942 | 103.67 |
ENSRNOT00000051414
ENSRNOT00000017494 |
Ndrg4
|
NDRG family member 4 |
chr14_+_83752393 | 101.84 |
ENSRNOT00000081123
|
Selenom
|
selenoprotein M |
chr4_-_39102807 | 101.74 |
ENSRNOT00000052063
|
Thsd7a
|
thrombospondin type 1 domain containing 7A |
chr10_+_86303727 | 101.47 |
ENSRNOT00000037752
|
Ppp1r1b
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr4_-_71713063 | 101.01 |
ENSRNOT00000059447
|
Fam131b
|
family with sequence similarity 131, member B |
chr3_+_92403582 | 100.05 |
ENSRNOT00000064282
|
Pamr1
|
peptidase domain containing associated with muscle regeneration 1 |
chr19_+_14653198 | 98.93 |
ENSRNOT00000020017
|
Rasd2
|
RASD family, member 2 |
chr10_+_65586504 | 98.89 |
ENSRNOT00000015535
ENSRNOT00000046388 |
Aldoc
|
aldolase, fructose-bisphosphate C |
chr7_-_50638798 | 98.29 |
ENSRNOT00000048880
|
Syt1
|
synaptotagmin 1 |
chr16_+_26906716 | 96.90 |
ENSRNOT00000064297
|
Cpe
|
carboxypeptidase E |
chr3_+_145032200 | 96.83 |
ENSRNOT00000068210
|
Syndig1
|
synapse differentiation inducing 1 |
chrX_-_29648359 | 96.54 |
ENSRNOT00000086721
ENSRNOT00000006777 |
Gpm6b
|
glycoprotein m6b |
chr6_-_147172813 | 96.29 |
ENSRNOT00000066545
|
Itgb8
|
integrin subunit beta 8 |
chr1_+_33910912 | 96.05 |
ENSRNOT00000044690
|
Irx1
|
iroquois homeobox 1 |
chr14_-_86297623 | 95.31 |
ENSRNOT00000067162
ENSRNOT00000081607 ENSRNOT00000085265 |
Camk2b
|
calcium/calmodulin-dependent protein kinase II beta |
chr9_+_20251521 | 94.87 |
ENSRNOT00000005535
|
LOC100911625
|
gamma-enolase-like |
chr6_-_8346197 | 94.82 |
ENSRNOT00000061826
|
Prepl
|
prolyl endopeptidase-like |
chr14_-_112946875 | 94.42 |
ENSRNOT00000081981
|
LOC103690141
|
coiled-coil domain-containing protein 85A-like |
chr5_-_40237591 | 94.33 |
ENSRNOT00000011393
|
Fut9
|
fucosyltransferase 9 |
chrX_+_29430831 | 93.85 |
ENSRNOT00000068337
ENSRNOT00000087621 |
Egfl6
|
EGF-like-domain, multiple 6 |
chr14_+_39154529 | 93.77 |
ENSRNOT00000003191
|
Gabra4
|
gamma-aminobutyric acid type A receptor alpha4 subunit |
chr5_-_158439078 | 93.05 |
ENSRNOT00000025517
|
Klhdc7a
|
kelch domain containing 7A |
chr14_+_2194933 | 91.99 |
ENSRNOT00000061720
|
Cplx1
|
complexin 1 |
chr7_+_94130852 | 91.19 |
ENSRNOT00000011485
|
Mal2
|
mal, T-cell differentiation protein 2 |
chr3_+_113318563 | 90.12 |
ENSRNOT00000089230
|
Ckmt1
|
creatine kinase, mitochondrial 1 |
chr16_+_20691978 | 89.90 |
ENSRNOT00000038139
ENSRNOT00000082319 |
Tmem59l
|
transmembrane protein 59-like |
chr20_+_41100071 | 89.89 |
ENSRNOT00000000658
|
Tspyl4
|
TSPY-like 4 |
chr17_-_18592750 | 89.89 |
ENSRNOT00000065742
|
Cap2
|
CAP, adenylate cyclase-associated protein, 2 (yeast) |
chr1_-_100671074 | 89.75 |
ENSRNOT00000027132
|
Myh14
|
myosin heavy chain 14 |
chr7_-_70552897 | 89.42 |
ENSRNOT00000080594
|
Kif5a
|
kinesin family member 5A |
chr6_+_3657325 | 89.42 |
ENSRNOT00000010927
|
Tmem178a
|
transmembrane protein 178A |
chrX_+_144445795 | 89.22 |
ENSRNOT00000048467
|
RGD1561327
|
similar to melanoma antigen family A, 10 |
chr12_-_38782010 | 88.65 |
ENSRNOT00000001813
|
Wdr66
|
WD repeat domain 66 |
chr6_+_8284878 | 87.73 |
ENSRNOT00000009581
|
Slc3a1
|
solute carrier family 3 member 1 |
chr7_-_145154131 | 87.22 |
ENSRNOT00000055271
|
Ppp1r1a
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
chr10_+_65586993 | 87.04 |
ENSRNOT00000086036
|
Aldoc
|
aldolase, fructose-bisphosphate C |
chr12_-_22211071 | 86.80 |
ENSRNOT00000087817
ENSRNOT00000001910 |
Actl6b
|
actin-like 6B |
chr1_+_91433030 | 86.19 |
ENSRNOT00000015205
|
Slc7a10
|
solute carrier family 7 member 10 |
chr6_+_29977797 | 86.15 |
ENSRNOT00000071784
|
Fkbp1b
|
FK506 binding protein 1B |
chr17_-_48562838 | 85.99 |
ENSRNOT00000017102
ENSRNOT00000084702 |
Amph
|
amphiphysin |
chr14_-_78707861 | 85.93 |
ENSRNOT00000091927
|
Ppp2r2c
|
protein phosphatase 2, regulatory subunit B, gamma |
chr9_+_79630604 | 85.85 |
ENSRNOT00000021539
ENSRNOT00000083979 |
Tmem169
|
transmembrane protein 169 |
chr14_+_77380262 | 84.82 |
ENSRNOT00000008030
|
Nsg1
|
neuron specific gene family member 1 |
chr1_+_105349069 | 84.78 |
ENSRNOT00000056030
|
Nell1
|
neural EGFL like 1 |
chr15_+_43007908 | 84.76 |
ENSRNOT00000084753
ENSRNOT00000091567 ENSRNOT00000087709 |
Stmn4
|
stathmin 4 |
chr1_-_102106127 | 83.76 |
ENSRNOT00000028685
|
Kcnj11
|
potassium voltage-gated channel subfamily J member 11 |
chr10_+_92337879 | 83.47 |
ENSRNOT00000042984
|
Mapt
|
microtubule-associated protein tau |
chr8_-_57255263 | 83.44 |
ENSRNOT00000028972
|
LOC100125362
|
hypothetical protein LOC100125362 |
chr12_+_943006 | 83.34 |
ENSRNOT00000001449
|
Kl
|
Klotho |
chr2_-_187372652 | 83.01 |
ENSRNOT00000025496
ENSRNOT00000083116 |
Bcan
|
brevican |
chr6_+_44009872 | 82.27 |
ENSRNOT00000082657
|
Mboat2
|
membrane bound O-acyltransferase domain containing 2 |
chr4_+_49941304 | 81.03 |
ENSRNOT00000008719
|
Ptprz1
|
protein tyrosine phosphatase, receptor type Z1 |
chr15_+_33600102 | 80.33 |
ENSRNOT00000022664
|
Cmtm5
|
CKLF-like MARVEL transmembrane domain containing 5 |
chr10_+_47282208 | 80.19 |
ENSRNOT00000057953
|
Kcnj12
|
potassium voltage-gated channel subfamily J member 12 |
chr8_+_7128656 | 80.16 |
ENSRNOT00000038313
|
Pgr
|
progesterone receptor |
chr5_+_147323240 | 79.73 |
ENSRNOT00000047152
|
Fndc5
|
fibronectin type III domain containing 5 |
chr1_+_36185916 | 79.27 |
ENSRNOT00000041762
|
Ube2ql1
|
ubiquitin-conjugating enzyme E2Q family-like 1 |
chr9_-_44237117 | 78.95 |
ENSRNOT00000068496
|
RGD1310819
|
similar to putative protein (5S487) |
chr19_+_561727 | 78.91 |
ENSRNOT00000016259
ENSRNOT00000081547 |
Rrad
|
RRAD, Ras related glycolysis inhibitor and calcium channel regulator |
chr10_+_47281786 | 78.82 |
ENSRNOT00000089123
|
Kcnj12
|
potassium voltage-gated channel subfamily J member 12 |
chr7_+_54980120 | 78.77 |
ENSRNOT00000005690
ENSRNOT00000005773 |
Kcnc2
|
potassium voltage-gated channel subfamily C member 2 |
chr14_-_67170361 | 78.62 |
ENSRNOT00000005477
|
Slit2
|
slit guidance ligand 2 |
chr3_-_153893847 | 78.50 |
ENSRNOT00000085938
|
LOC100911769
|
band 4.1-like protein 1-like |
chr7_+_117723263 | 78.42 |
ENSRNOT00000085152
|
Kifc2
|
kinesin family member C2 |
chr7_-_117151694 | 78.12 |
ENSRNOT00000051294
|
Nrbp2
|
nuclear receptor binding protein 2 |
chr19_-_9777465 | 77.94 |
ENSRNOT00000017413
|
Ndrg4
|
NDRG family member 4 |
chr5_+_120250616 | 77.92 |
ENSRNOT00000070967
|
Ak4
|
adenylate kinase 4 |
chr7_-_140356209 | 77.88 |
ENSRNOT00000077856
|
Rnd1
|
Rho family GTPase 1 |
chr10_+_27973681 | 77.69 |
ENSRNOT00000004970
|
Gabrb2
|
gamma-aminobutyric acid type A receptor beta 2 subunit |
chr16_-_39719187 | 77.60 |
ENSRNOT00000092971
|
Gpm6a
|
glycoprotein m6a |
chr10_-_103816287 | 77.60 |
ENSRNOT00000004477
|
Grin2c
|
glutamate ionotropic receptor NMDA type subunit 2C |
chr3_+_110574417 | 77.38 |
ENSRNOT00000031231
|
Disp2
|
dispatched RND transporter family member 2 |
chr2_-_30127269 | 77.35 |
ENSRNOT00000023869
|
Cartpt
|
CART prepropeptide |
chr13_-_90676629 | 76.92 |
ENSRNOT00000058143
|
Atp1a2
|
ATPase Na+/K+ transporting subunit alpha 2 |
chr13_-_82758004 | 76.92 |
ENSRNOT00000003932
|
Atp1b1
|
ATPase Na+/K+ transporting subunit beta 1 |
chr3_-_176816114 | 76.71 |
ENSRNOT00000079262
ENSRNOT00000018697 |
Stmn3
|
stathmin 3 |
chr3_-_176644951 | 76.67 |
ENSRNOT00000049961
|
Kcnq2
|
potassium voltage-gated channel subfamily Q member 2 |
chr18_+_83471342 | 76.58 |
ENSRNOT00000019384
|
Neto1
|
neuropilin and tolloid like 1 |
chr10_+_91710495 | 76.10 |
ENSRNOT00000033276
|
Rprml
|
reprimo-like |
chr19_-_37427989 | 76.09 |
ENSRNOT00000022863
|
Tppp3
|
tubulin polymerization-promoting protein family member 3 |
chr14_-_43072843 | 75.97 |
ENSRNOT00000064263
|
Limch1
|
LIM and calponin homology domains 1 |
chr7_-_126461658 | 75.96 |
ENSRNOT00000081032
|
Wnt7b
|
wingless-type MMTV integration site family, member 7B |
chr3_+_151310598 | 75.60 |
ENSRNOT00000092194
|
Mmp24
|
matrix metallopeptidase 24 |
chr8_-_130429132 | 75.51 |
ENSRNOT00000026261
|
Hhatl
|
hedgehog acyltransferase-like |
chrX_-_142131545 | 75.22 |
ENSRNOT00000077402
|
Fgf13
|
fibroblast growth factor 13 |
chr9_-_88357182 | 75.02 |
ENSRNOT00000041176
|
Col4a4
|
collagen type IV alpha 4 chain |
chr4_+_7076759 | 74.55 |
ENSRNOT00000066598
|
Smarcd3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3 |
chr15_-_33629699 | 73.86 |
ENSRNOT00000023302
|
Myh6
|
myosin heavy chain 6 |
chrX_-_15707436 | 73.77 |
ENSRNOT00000085907
|
Syp
|
synaptophysin |
chr1_+_88750462 | 73.72 |
ENSRNOT00000028247
|
LOC108348122
|
CAP-Gly domain-containing linker protein 3 |
chr2_+_34186091 | 73.64 |
ENSRNOT00000016129
|
Sgtb
|
small glutamine rich tetratricopeptide repeat containing beta |
chr1_+_80195532 | 73.61 |
ENSRNOT00000022528
|
Rtn2
|
reticulon 2 |
chr1_+_39811314 | 73.35 |
ENSRNOT00000022046
|
Ppp1r14c
|
protein phosphatase 1, regulatory (inhibitor) subunit 14c |
chr9_-_104350308 | 73.29 |
ENSRNOT00000033958
|
Slco4c1
|
solute carrier organic anion transporter family, member 4C1 |
chr16_+_7292096 | 72.84 |
ENSRNOT00000025606
|
Tnnc1
|
troponin C1, slow skeletal and cardiac type |
chr4_-_157294047 | 72.59 |
ENSRNOT00000005601
|
Eno2
|
enolase 2 |
chr3_-_120233655 | 72.47 |
ENSRNOT00000020870
|
Mal
|
mal, T-cell differentiation protein |
chr14_-_18839420 | 72.45 |
ENSRNOT00000034090
|
Cxcl3
|
chemokine (C-X-C motif) ligand 3 |
chr5_-_16140896 | 72.44 |
ENSRNOT00000029503
|
Xkr4
|
XK related 4 |
chr8_+_29453643 | 72.34 |
ENSRNOT00000090643
|
Opcml
|
opioid binding protein/cell adhesion molecule-like |
chr1_-_90978907 | 72.31 |
ENSRNOT00000072819
|
Clip3
|
CAP-GLY domain containing linker protein 3 |
chr7_+_141249044 | 72.24 |
ENSRNOT00000084911
|
Aqp5
|
aquaporin 5 |
chr8_+_27777179 | 71.48 |
ENSRNOT00000009825
|
B3gat1
|
beta-1,3-glucuronyltransferase 1 |
chr5_-_135024447 | 71.40 |
ENSRNOT00000078736
|
Tspan1
|
tetraspanin 1 |
chr5_-_172809353 | 71.32 |
ENSRNOT00000022246
|
Gabrd
|
gamma-aminobutyric acid type A receptor delta subunit |
chr1_-_198382614 | 71.20 |
ENSRNOT00000055016
|
Asphd1
|
aspartate beta-hydroxylase domain containing 1 |
chr3_+_152552822 | 71.19 |
ENSRNOT00000089719
|
Epb41l1
|
erythrocyte membrane protein band 4.1-like 1 |
chr6_+_26797126 | 70.70 |
ENSRNOT00000010586
|
Cgref1
|
cell growth regulator with EF hand domain 1 |
chr1_-_89360733 | 70.62 |
ENSRNOT00000028544
|
Mag
|
myelin-associated glycoprotein |
chr7_-_93502571 | 70.49 |
ENSRNOT00000077033
ENSRNOT00000076080 |
Samd12
|
sterile alpha motif domain containing 12 |
chr7_+_11356118 | 70.30 |
ENSRNOT00000041325
|
Atcay
|
ATCAY, caytaxin |
chr5_+_128501847 | 70.26 |
ENSRNOT00000010645
|
Rab3b
|
RAB3B, member RAS oncogene family |
chr2_-_21698937 | 70.20 |
ENSRNOT00000080165
|
AABR07007642.1
|
|
chr10_+_56228043 | 70.18 |
ENSRNOT00000015769
|
Sat2
|
spermidine/spermine N1-acetyltransferase family member 2 |
chr14_-_112946204 | 70.08 |
ENSRNOT00000056813
|
LOC103690141
|
coiled-coil domain-containing protein 85A-like |
chr3_+_58632476 | 69.94 |
ENSRNOT00000010630
|
Rapgef4
|
Rap guanine nucleotide exchange factor 4 |
chr7_-_139063752 | 69.80 |
ENSRNOT00000072309
|
LOC102551901
|
protein lifeguard 2-like |
chr7_-_119441487 | 69.75 |
ENSRNOT00000067635
|
Pvalb
|
parvalbumin |
chr16_+_7303578 | 69.54 |
ENSRNOT00000025656
|
Sema3g
|
semaphorin 3G |
chr4_+_13405136 | 69.35 |
ENSRNOT00000091004
|
Gnai1
|
G protein subunit alpha i1 |
chr12_+_52452273 | 69.14 |
ENSRNOT00000056680
ENSRNOT00000088381 |
Pxmp2
|
peroxisomal membrane protein 2 |
chr6_+_79254339 | 69.08 |
ENSRNOT00000073970
|
Sstr1
|
somatostatin receptor 1 |
chr1_-_215834704 | 68.89 |
ENSRNOT00000073850
|
Igf2
|
insulin-like growth factor 2 |
chr11_+_32655616 | 68.70 |
ENSRNOT00000084412
ENSRNOT00000034383 |
Clic6
|
chloride intracellular channel 6 |
chr16_-_5795825 | 68.60 |
ENSRNOT00000048043
|
Cacna2d3
|
calcium voltage-gated channel auxiliary subunit alpha2delta 3 |
chr4_-_117490721 | 68.56 |
ENSRNOT00000021103
|
Nat8f3
|
N-acetyltransferase 8 (GCN5-related) family member 3 |
chr9_-_100253609 | 68.53 |
ENSRNOT00000036061
|
Kif1a
|
kinesin family member 1A |
chr5_+_156876706 | 68.53 |
ENSRNOT00000021864
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr6_-_28464118 | 68.41 |
ENSRNOT00000068214
|
Efr3b
|
EFR3 homolog B |
chr1_-_170404056 | 68.18 |
ENSRNOT00000024402
|
Apbb1
|
amyloid beta precursor protein binding family B member 1 |
chr2_-_211207465 | 68.15 |
ENSRNOT00000027263
|
Celsr2
|
cadherin, EGF LAG seven-pass G-type receptor 2 |
chr3_+_79713567 | 68.06 |
ENSRNOT00000012110
|
C1qtnf4
|
C1q and tumor necrosis factor related protein 4 |
chr13_-_89565813 | 68.00 |
ENSRNOT00000004347
|
Pcp4l1
|
Purkinje cell protein 4-like 1 |
chr10_-_14056169 | 68.00 |
ENSRNOT00000017833
|
Syngr3
|
synaptogyrin 3 |
chr14_+_60123169 | 67.98 |
ENSRNOT00000006610
|
Sel1l3
|
SEL1L family member 3 |
chr7_-_72328128 | 67.75 |
ENSRNOT00000008227
|
Tspyl5
|
TSPY-like 5 |
chr4_-_145147397 | 67.37 |
ENSRNOT00000010347
|
Lhfpl4
|
lipoma HMGIC fusion partner-like 4 |
chr10_-_89958805 | 67.33 |
ENSRNOT00000084266
|
Mpp3
|
membrane palmitoylated protein 3 |
chr14_+_100217289 | 67.32 |
ENSRNOT00000077171
ENSRNOT00000007104 |
Cnrip1
|
cannabinoid receptor interacting protein 1 |
chr4_-_123040609 | 67.32 |
ENSRNOT00000070832
|
Wnt7a
|
wingless-type MMTV integration site family, member 7A |
chr7_-_12793711 | 67.23 |
ENSRNOT00000013762
|
Palm
|
paralemmin |
chr1_-_72727112 | 67.20 |
ENSRNOT00000031172
|
Brsk1
|
BR serine/threonine kinase 1 |
chr16_-_18974729 | 67.18 |
ENSRNOT00000086424
ENSRNOT00000064060 |
Tmem38a
|
transmembrane protein 38a |
chr6_-_147172022 | 66.99 |
ENSRNOT00000080675
|
Itgb8
|
integrin subunit beta 8 |
chr20_+_19318250 | 66.92 |
ENSRNOT00000000299
|
Phyhipl
|
phytanoyl-CoA 2-hydroxylase interacting protein-like |
chr9_+_9961021 | 66.91 |
ENSRNOT00000075767
|
Tubb4a
|
tubulin, beta 4A class IVa |
chr5_-_147303346 | 66.91 |
ENSRNOT00000009153
|
Hpca
|
hippocalcin |
chr1_-_212548730 | 66.77 |
ENSRNOT00000089729
|
Caly
|
calcyon neuron-specific vesicular protein |
chr3_+_113257688 | 66.77 |
ENSRNOT00000019320
|
Map1a
|
microtubule-associated protein 1A |
chr1_-_64405149 | 66.59 |
ENSRNOT00000089944
|
Cacng7
|
calcium voltage-gated channel auxiliary subunit gamma 7 |
chr5_+_70441123 | 66.53 |
ENSRNOT00000087517
|
Fsd1l
|
fibronectin type III and SPRY domain containing 1-like |
chr15_-_82482009 | 66.34 |
ENSRNOT00000011926
|
Dach1
|
dachshund family transcription factor 1 |
chrX_-_134866210 | 66.32 |
ENSRNOT00000005331
|
Apln
|
apelin |
chr7_+_145117951 | 66.17 |
ENSRNOT00000055272
|
Pde1b
|
phosphodiesterase 1B |
chr2_+_226900619 | 66.12 |
ENSRNOT00000019638
|
Pde5a
|
phosphodiesterase 5A |
chr1_-_54748763 | 65.96 |
ENSRNOT00000074549
|
LOC100911027
|
protein MAL2-like |
chr4_-_51844331 | 65.87 |
ENSRNOT00000003593
|
Gpr37
|
G protein-coupled receptor 37 |
chr1_+_219964429 | 65.76 |
ENSRNOT00000088288
|
Sptbn2
|
spectrin, beta, non-erythrocytic 2 |
chr10_+_92289107 | 65.66 |
ENSRNOT00000050070
|
Mapt
|
microtubule-associated protein tau |
chr7_-_11353713 | 65.61 |
ENSRNOT00000061132
|
Zfr2
|
zinc finger RNA binding protein 2 |
chr11_-_83867203 | 65.59 |
ENSRNOT00000002394
|
Chrd
|
chordin |
chr17_-_9762813 | 65.50 |
ENSRNOT00000033749
|
Slc34a1
|
solute carrier family 34 member 1 |
chr3_+_113319456 | 65.48 |
ENSRNOT00000051354
|
Ckmt1
|
creatine kinase, mitochondrial 1 |
chr14_-_82287108 | 65.20 |
ENSRNOT00000023144
|
Fgfr3
|
fibroblast growth factor receptor 3 |
chr16_-_21089508 | 65.09 |
ENSRNOT00000072565
|
Hapln4
|
hyaluronan and proteoglycan link protein 4 |
chr11_+_57207656 | 64.97 |
ENSRNOT00000038207
ENSRNOT00000085754 |
Plcxd2
|
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
chr10_+_109904259 | 64.96 |
ENSRNOT00000073886
|
Rac3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
chrX_+_151103576 | 64.95 |
ENSRNOT00000015401
|
Slitrk2
|
SLIT and NTRK-like family, member 2 |
chr1_-_89483988 | 64.89 |
ENSRNOT00000028603
|
Fxyd7
|
FXYD domain-containing ion transport regulator 7 |
chr16_+_21061237 | 64.82 |
ENSRNOT00000092136
|
Ncan
|
neurocan |
chr10_-_51669297 | 64.56 |
ENSRNOT00000071595
|
Arhgap44
|
Rho GTPase activating protein 44 |
chr2_+_53859737 | 64.33 |
ENSRNOT00000065313
|
Oxct1
|
3-oxoacid CoA transferase 1 |
chr19_-_12942943 | 64.08 |
ENSRNOT00000064105
ENSRNOT00000090886 |
Large1
|
LARGE xylosyl- and glucuronyltransferase 1 |
chr1_+_89215266 | 64.00 |
ENSRNOT00000093612
ENSRNOT00000084799 |
Dmkn
|
dermokine |
chr5_+_166533181 | 63.99 |
ENSRNOT00000045063
|
Clstn1
|
calsyntenin 1 |
chr9_-_88356716 | 63.91 |
ENSRNOT00000077503
|
Col4a4
|
collagen type IV alpha 4 chain |
chrX_+_15035569 | 63.81 |
ENSRNOT00000006491
ENSRNOT00000078392 |
Porcn
|
porcupine homolog (Drosophila) |
chr3_+_56862691 | 63.80 |
ENSRNOT00000087712
|
Gad1
|
glutamate decarboxylase 1 |
chr10_-_15166457 | 63.66 |
ENSRNOT00000026676
|
Metrn
|
meteorin, glial cell differentiation regulator |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
51.7 | 51.7 | GO:1904684 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) |
46.7 | 233.5 | GO:0021966 | corticospinal neuron axon guidance(GO:0021966) |
45.7 | 137.2 | GO:0072054 | renal outer medulla development(GO:0072054) |
45.3 | 181.4 | GO:1903279 | regulation of calcium:sodium antiporter activity(GO:1903279) |
45.3 | 136.0 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
43.4 | 130.2 | GO:0051867 | general adaptation syndrome, behavioral process(GO:0051867) |
43.1 | 172.2 | GO:0090427 | activation of meiosis(GO:0090427) |
43.0 | 85.9 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) |
41.9 | 125.6 | GO:0060683 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling(GO:0060683) embryonic lung development(GO:1990401) |
41.7 | 208.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
41.7 | 125.0 | GO:0097187 | dentinogenesis(GO:0097187) |
41.5 | 124.6 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
40.6 | 121.8 | GO:0003365 | establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
40.3 | 40.3 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
39.2 | 156.9 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
39.2 | 39.2 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
38.7 | 309.9 | GO:1900034 | regulation of cellular response to heat(GO:1900034) |
38.5 | 115.4 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
38.3 | 76.7 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
38.3 | 114.9 | GO:1904700 | granulosa cell apoptotic process(GO:1904700) regulation of granulosa cell apoptotic process(GO:1904708) |
38.1 | 38.1 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
38.1 | 114.4 | GO:0033058 | directional locomotion(GO:0033058) |
36.5 | 475.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
36.4 | 36.4 | GO:0097213 | regulation of lysosomal membrane permeability(GO:0097213) positive regulation of lysosomal membrane permeability(GO:0097214) |
36.2 | 181.1 | GO:0050828 | regulation of liquid surface tension(GO:0050828) |
35.2 | 105.7 | GO:1905242 | response to 3,3',5-triiodo-L-thyronine(GO:1905242) cellular response to 3,3',5-triiodo-L-thyronine(GO:1905243) |
35.1 | 210.8 | GO:0033292 | T-tubule organization(GO:0033292) |
34.7 | 104.1 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
34.4 | 137.7 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
34.4 | 137.6 | GO:0098886 | modification of dendritic spine(GO:0098886) |
34.3 | 103.0 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
33.7 | 168.7 | GO:0051612 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
33.7 | 33.7 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
33.4 | 334.2 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
33.3 | 133.4 | GO:1904009 | cellular response to monosodium glutamate(GO:1904009) |
32.4 | 97.3 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
32.2 | 96.5 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
32.1 | 96.3 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
31.9 | 255.3 | GO:0046959 | habituation(GO:0046959) |
31.5 | 126.1 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
30.5 | 30.5 | GO:2000172 | regulation of branching morphogenesis of a nerve(GO:2000172) |
30.3 | 212.4 | GO:0036376 | sodium ion export from cell(GO:0036376) |
30.0 | 119.9 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
29.6 | 177.5 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
29.5 | 29.5 | GO:2000277 | positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
29.4 | 264.7 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
29.4 | 235.1 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
29.3 | 87.8 | GO:1900238 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:0035793) regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway(GO:1900238) positive regulation of metanephric mesenchymal cell migration(GO:2000591) |
29.3 | 29.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
28.9 | 115.8 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
28.7 | 114.9 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
28.5 | 199.8 | GO:1904647 | response to rotenone(GO:1904647) |
28.4 | 56.7 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
28.3 | 85.0 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
28.2 | 225.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
27.5 | 220.0 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
27.4 | 164.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
27.4 | 82.1 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
27.3 | 109.1 | GO:0050975 | sensory perception of touch(GO:0050975) |
27.2 | 81.5 | GO:1990792 | response to glial cell derived neurotrophic factor(GO:1990790) cellular response to glial cell derived neurotrophic factor(GO:1990792) |
27.2 | 54.3 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
27.1 | 189.7 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
27.1 | 81.3 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
26.9 | 53.8 | GO:0030913 | paranodal junction assembly(GO:0030913) |
26.9 | 53.7 | GO:0008050 | female courtship behavior(GO:0008050) |
26.8 | 187.5 | GO:0035934 | corticosterone secretion(GO:0035934) |
26.7 | 106.9 | GO:0032919 | spermine acetylation(GO:0032919) |
26.6 | 26.6 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
26.4 | 105.4 | GO:1903244 | positive regulation of cardiac muscle adaptation(GO:0010615) positive regulation of cardiac muscle hypertrophy in response to stress(GO:1903244) |
26.2 | 105.0 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
26.1 | 104.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
26.1 | 78.2 | GO:0071529 | cementum mineralization(GO:0071529) |
25.9 | 77.8 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
25.7 | 51.5 | GO:0045113 | regulation of integrin biosynthetic process(GO:0045113) |
25.7 | 25.7 | GO:1903937 | response to acrylamide(GO:1903937) |
25.7 | 102.6 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
25.6 | 102.3 | GO:0032439 | endosome localization(GO:0032439) |
25.5 | 51.1 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
25.4 | 50.7 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
25.3 | 50.6 | GO:0038189 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) |
25.2 | 201.4 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
25.1 | 276.2 | GO:1904861 | excitatory synapse assembly(GO:1904861) |
25.0 | 25.0 | GO:1905006 | negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905006) |
25.0 | 25.0 | GO:0060857 | establishment of glial blood-brain barrier(GO:0060857) |
25.0 | 74.9 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
25.0 | 149.8 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
24.9 | 74.8 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
24.8 | 74.5 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
24.8 | 24.8 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
24.8 | 24.8 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
24.7 | 197.5 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
24.6 | 221.6 | GO:0060371 | regulation of atrial cardiac muscle cell membrane depolarization(GO:0060371) |
24.6 | 172.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
24.5 | 98.2 | GO:1902256 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
24.5 | 24.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
24.4 | 24.4 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
24.2 | 48.5 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
24.2 | 193.7 | GO:1990034 | calcium ion export from cell(GO:1990034) |
24.2 | 96.8 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
24.1 | 72.3 | GO:1901660 | calcium ion export(GO:1901660) |
24.1 | 144.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
23.9 | 95.5 | GO:0021590 | cerebellum maturation(GO:0021590) |
23.9 | 47.7 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
23.8 | 23.8 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
23.8 | 333.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
23.8 | 166.3 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
23.7 | 213.1 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
23.7 | 71.0 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
23.6 | 70.9 | GO:0042489 | negative regulation of odontogenesis of dentin-containing tooth(GO:0042489) |
23.6 | 188.6 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
23.5 | 70.5 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
23.4 | 70.3 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
23.4 | 117.0 | GO:2000768 | positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
23.4 | 46.7 | GO:0045105 | intermediate filament polymerization or depolymerization(GO:0045105) |
23.3 | 23.3 | GO:0021578 | hindbrain maturation(GO:0021578) central nervous system maturation(GO:0021626) |
23.2 | 69.7 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
23.2 | 69.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
23.2 | 23.2 | GO:0032470 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
23.1 | 115.4 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
23.1 | 299.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
23.1 | 69.2 | GO:0006710 | androgen catabolic process(GO:0006710) |
23.1 | 138.3 | GO:0042940 | D-amino acid transport(GO:0042940) |
23.0 | 69.1 | GO:0006574 | valine catabolic process(GO:0006574) |
22.9 | 22.9 | GO:1904000 | positive regulation of eating behavior(GO:1904000) |
22.9 | 68.7 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
22.9 | 91.4 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
22.8 | 91.3 | GO:0060313 | negative regulation of blood vessel remodeling(GO:0060313) |
22.8 | 136.9 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
22.8 | 136.8 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
22.8 | 68.4 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
22.7 | 68.1 | GO:1900200 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
22.7 | 68.1 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
22.7 | 68.1 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
22.7 | 22.7 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
22.7 | 68.0 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
22.6 | 22.6 | GO:0006533 | aspartate catabolic process(GO:0006533) |
22.4 | 89.7 | GO:1904204 | regulation of skeletal muscle hypertrophy(GO:1904204) |
22.3 | 89.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
22.3 | 66.9 | GO:0010625 | positive regulation of Schwann cell proliferation(GO:0010625) |
22.3 | 66.8 | GO:0015820 | leucine transport(GO:0015820) |
22.2 | 22.2 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
22.2 | 88.7 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
22.1 | 66.2 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
21.9 | 21.9 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
21.9 | 43.7 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
21.8 | 21.8 | GO:0072053 | renal inner medulla development(GO:0072053) |
21.7 | 65.1 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
21.7 | 65.0 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
21.7 | 151.6 | GO:0061621 | NADH regeneration(GO:0006735) canonical glycolysis(GO:0061621) glucose catabolic process to pyruvate(GO:0061718) |
21.6 | 173.1 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
21.5 | 107.7 | GO:0030070 | insulin processing(GO:0030070) |
21.5 | 64.6 | GO:0061744 | motor behavior(GO:0061744) |
21.5 | 257.8 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
21.4 | 107.2 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
21.2 | 21.2 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
21.2 | 148.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
21.1 | 63.3 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
20.9 | 62.8 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
20.9 | 41.9 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
20.9 | 41.8 | GO:0046038 | guanine salvage(GO:0006178) GMP catabolic process(GO:0046038) guanine biosynthetic process(GO:0046099) |
20.9 | 376.3 | GO:0071625 | vocalization behavior(GO:0071625) |
20.9 | 83.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
20.9 | 83.5 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
20.8 | 124.9 | GO:0021759 | globus pallidus development(GO:0021759) |
20.8 | 249.7 | GO:0071420 | cellular response to histamine(GO:0071420) |
20.7 | 82.9 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
20.7 | 207.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
20.6 | 20.6 | GO:0021834 | chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration(GO:0021834) |
20.5 | 61.4 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
20.5 | 143.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
20.4 | 81.7 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) |
20.4 | 61.2 | GO:0009216 | purine deoxyribonucleoside triphosphate biosynthetic process(GO:0009216) |
20.4 | 81.5 | GO:0060677 | ureteric bud elongation(GO:0060677) |
20.4 | 122.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
20.3 | 60.9 | GO:0003322 | pancreatic A cell development(GO:0003322) forebrain-midbrain boundary formation(GO:0021905) somatic motor neuron fate commitment(GO:0021917) regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment(GO:0021918) sensory neuron migration(GO:1904937) |
20.2 | 40.5 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
20.2 | 120.9 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
20.0 | 80.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
19.9 | 19.9 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
19.9 | 59.6 | GO:2001205 | negative regulation of osteoclast development(GO:2001205) |
19.7 | 39.5 | GO:0097120 | receptor localization to synapse(GO:0097120) |
19.7 | 118.0 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
19.6 | 19.6 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
19.6 | 58.8 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
19.6 | 58.8 | GO:0006543 | glutamine catabolic process(GO:0006543) |
19.6 | 450.0 | GO:1900449 | regulation of glutamate receptor signaling pathway(GO:1900449) |
19.6 | 39.1 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
19.4 | 19.4 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
19.3 | 77.4 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
19.3 | 19.3 | GO:0039526 | suppression by virus of host apoptotic process(GO:0019050) modulation by virus of host apoptotic process(GO:0039526) |
19.2 | 76.9 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
19.2 | 76.8 | GO:1903575 | cornified envelope assembly(GO:1903575) |
19.2 | 19.2 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
19.2 | 153.3 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
19.1 | 38.3 | GO:0072197 | ureter morphogenesis(GO:0072197) metanephric nephron tubule formation(GO:0072289) |
19.1 | 95.5 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
19.1 | 76.4 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
19.1 | 19.1 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
19.0 | 171.2 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
19.0 | 19.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
19.0 | 75.8 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
18.9 | 56.7 | GO:1904057 | negative regulation of sensory perception of pain(GO:1904057) |
18.9 | 37.7 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
18.7 | 18.7 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
18.6 | 92.9 | GO:0002003 | angiotensin maturation(GO:0002003) |
18.6 | 130.1 | GO:0098909 | regulation of cardiac muscle cell action potential involved in regulation of contraction(GO:0098909) |
18.5 | 74.0 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
18.5 | 55.5 | GO:0042822 | pyridoxal phosphate metabolic process(GO:0042822) |
18.4 | 55.2 | GO:0010747 | positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) |
18.4 | 36.8 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
18.3 | 109.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
18.3 | 73.0 | GO:1904220 | regulation of serine C-palmitoyltransferase activity(GO:1904220) |
18.2 | 182.4 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
18.2 | 72.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
18.2 | 36.4 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
18.2 | 109.0 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
17.9 | 71.7 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
17.9 | 179.2 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
17.9 | 17.9 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
17.9 | 89.5 | GO:0006842 | tricarboxylic acid transport(GO:0006842) |
17.8 | 71.4 | GO:0031179 | peptide modification(GO:0031179) |
17.8 | 17.8 | GO:0002086 | diaphragm contraction(GO:0002086) |
17.8 | 337.3 | GO:0010107 | potassium ion import(GO:0010107) |
17.7 | 88.7 | GO:0097151 | positive regulation of inhibitory postsynaptic potential(GO:0097151) |
17.7 | 124.0 | GO:0007614 | short-term memory(GO:0007614) |
17.7 | 88.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
17.5 | 17.5 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
17.5 | 52.6 | GO:0060214 | endocardium formation(GO:0060214) |
17.5 | 122.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
17.5 | 244.4 | GO:0015693 | magnesium ion transport(GO:0015693) |
17.4 | 104.4 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
17.4 | 17.4 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
17.3 | 138.7 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
17.3 | 17.3 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
17.3 | 414.9 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
17.3 | 51.8 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
17.2 | 34.5 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
17.2 | 34.5 | GO:1902958 | neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036482) positive regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902958) regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903383) negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway(GO:1903384) |
17.2 | 51.6 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
17.2 | 17.2 | GO:0072284 | S-shaped body morphogenesis(GO:0072050) metanephric S-shaped body morphogenesis(GO:0072284) |
17.2 | 51.5 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
17.1 | 51.4 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
17.1 | 51.4 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
17.0 | 220.9 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
16.9 | 186.3 | GO:0015747 | urate transport(GO:0015747) |
16.9 | 152.4 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
16.9 | 50.8 | GO:0006083 | acetate metabolic process(GO:0006083) |
16.9 | 203.1 | GO:0009065 | glutamine family amino acid catabolic process(GO:0009065) |
16.9 | 50.8 | GO:0042891 | antibiotic transport(GO:0042891) |
16.9 | 33.8 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
16.9 | 33.8 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
16.9 | 33.8 | GO:0007619 | courtship behavior(GO:0007619) |
16.8 | 84.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
16.8 | 353.2 | GO:0007413 | axonal fasciculation(GO:0007413) |
16.8 | 33.6 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
16.8 | 16.8 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
16.6 | 33.3 | GO:0032423 | regulation of mismatch repair(GO:0032423) |
16.6 | 16.6 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
16.6 | 49.7 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
16.6 | 82.8 | GO:0060594 | mammary gland specification(GO:0060594) |
16.5 | 49.5 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
16.5 | 33.0 | GO:0003166 | bundle of His development(GO:0003166) |
16.5 | 33.0 | GO:2000437 | regulation of monocyte extravasation(GO:2000437) |
16.5 | 16.5 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
16.4 | 49.2 | GO:0051012 | microtubule sliding(GO:0051012) |
16.4 | 49.2 | GO:0001997 | positive regulation of the force of heart contraction by epinephrine-norepinephrine(GO:0001997) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
16.4 | 65.6 | GO:0060174 | limb bud formation(GO:0060174) |
16.4 | 163.7 | GO:0042053 | regulation of dopamine metabolic process(GO:0042053) |
16.4 | 32.7 | GO:0060437 | lung growth(GO:0060437) |
16.3 | 49.0 | GO:1904457 | positive regulation of neuronal action potential(GO:1904457) |
16.3 | 48.9 | GO:0021730 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) |
16.3 | 32.6 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
16.3 | 65.1 | GO:0046909 | intermembrane transport(GO:0046909) |
16.2 | 129.3 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
16.1 | 16.1 | GO:0072040 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) negative regulation of somatic stem cell population maintenance(GO:1904673) |
16.1 | 465.9 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
16.1 | 16.1 | GO:1903764 | regulation of potassium ion export across plasma membrane(GO:1903764) |
16.0 | 16.0 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
16.0 | 128.0 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
16.0 | 79.9 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
16.0 | 47.9 | GO:0060082 | eye blink reflex(GO:0060082) |
16.0 | 31.9 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
15.9 | 47.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
15.9 | 79.5 | GO:0008292 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
15.9 | 79.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
15.9 | 142.9 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
15.9 | 63.4 | GO:0021564 | vagus nerve development(GO:0021564) |
15.8 | 15.8 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
15.8 | 63.2 | GO:0002933 | lipid hydroxylation(GO:0002933) |
15.8 | 15.8 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
15.7 | 126.0 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
15.7 | 62.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
15.6 | 140.7 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
15.6 | 46.8 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
15.6 | 77.8 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
15.6 | 62.2 | GO:0098964 | dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
15.5 | 15.5 | GO:0031583 | phospholipase D-activating G-protein coupled receptor signaling pathway(GO:0031583) |
15.5 | 108.7 | GO:0016486 | peptide hormone processing(GO:0016486) |
15.5 | 46.5 | GO:0035625 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
15.4 | 77.2 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
15.4 | 61.7 | GO:0002118 | aggressive behavior(GO:0002118) |
15.3 | 46.0 | GO:0010265 | SCF complex assembly(GO:0010265) |
15.3 | 30.6 | GO:0090269 | fibroblast growth factor production(GO:0090269) regulation of fibroblast growth factor production(GO:0090270) |
15.3 | 30.5 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
15.2 | 75.9 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
15.2 | 197.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
15.1 | 75.7 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
15.1 | 30.3 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
15.1 | 105.4 | GO:0046710 | GDP metabolic process(GO:0046710) |
15.0 | 45.1 | GO:0021678 | third ventricle development(GO:0021678) |
15.0 | 45.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
15.0 | 74.9 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
15.0 | 59.9 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
15.0 | 15.0 | GO:1900673 | olefin metabolic process(GO:1900673) |
15.0 | 164.5 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
14.9 | 44.8 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
14.9 | 14.9 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
14.9 | 29.9 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
14.9 | 44.7 | GO:0045959 | negative regulation of complement activation, classical pathway(GO:0045959) |
14.9 | 14.9 | GO:0009644 | response to high light intensity(GO:0009644) |
14.9 | 14.9 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
14.9 | 89.3 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
14.9 | 29.8 | GO:1904954 | Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
14.9 | 59.5 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
14.8 | 162.4 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
14.8 | 103.3 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
14.7 | 44.2 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
14.7 | 587.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
14.7 | 29.4 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
14.6 | 73.1 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
14.5 | 87.2 | GO:0099526 | presynaptic signal transduction(GO:0098928) presynapse to nucleus signaling pathway(GO:0099526) |
14.5 | 29.1 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
14.5 | 202.9 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
14.5 | 29.0 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
14.5 | 43.5 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
14.5 | 14.5 | GO:0072144 | glomerular mesangial cell development(GO:0072144) |
14.5 | 28.9 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
14.5 | 86.7 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
14.4 | 43.2 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
14.4 | 158.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
14.4 | 28.7 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
14.4 | 86.1 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
14.3 | 100.2 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
14.3 | 28.6 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
14.3 | 42.9 | GO:0006713 | glucocorticoid catabolic process(GO:0006713) |
14.3 | 114.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
14.3 | 128.4 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
14.2 | 28.5 | GO:1904350 | regulation of protein catabolic process in the vacuole(GO:1904350) |
14.2 | 28.4 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
14.2 | 14.2 | GO:1904959 | regulation of cytochrome-c oxidase activity(GO:1904959) |
14.2 | 28.4 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
14.1 | 14.1 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
14.1 | 42.3 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
14.0 | 70.2 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
14.0 | 112.0 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
14.0 | 167.9 | GO:0006108 | malate metabolic process(GO:0006108) |
14.0 | 41.9 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
14.0 | 55.8 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
13.9 | 27.9 | GO:0007412 | axon target recognition(GO:0007412) |
13.9 | 41.6 | GO:0032053 | ciliary basal body organization(GO:0032053) |
13.8 | 41.4 | GO:0035106 | operant conditioning(GO:0035106) |
13.8 | 55.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
13.7 | 82.3 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
13.7 | 54.8 | GO:0015811 | L-cystine transport(GO:0015811) |
13.7 | 41.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
13.6 | 40.9 | GO:2001016 | positive regulation of skeletal muscle cell differentiation(GO:2001016) |
13.6 | 54.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
13.6 | 40.9 | GO:0060134 | prepulse inhibition(GO:0060134) |
13.6 | 81.4 | GO:0015871 | choline transport(GO:0015871) |
13.5 | 67.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
13.5 | 94.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
13.4 | 13.4 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
13.4 | 26.9 | GO:0071321 | cellular response to cGMP(GO:0071321) |
13.3 | 26.6 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
13.3 | 93.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
13.3 | 53.1 | GO:0051692 | cellular oligosaccharide catabolic process(GO:0051692) |
13.3 | 39.8 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
13.3 | 39.8 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
13.3 | 39.8 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
13.2 | 13.2 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
13.2 | 39.7 | GO:0032349 | positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
13.2 | 13.2 | GO:1904008 | response to monosodium glutamate(GO:1904008) |
13.2 | 52.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
13.2 | 13.2 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
13.2 | 39.5 | GO:0045161 | neuronal ion channel clustering(GO:0045161) |
13.1 | 39.4 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
13.1 | 52.6 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
13.1 | 65.6 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
13.1 | 13.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
13.1 | 104.8 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
13.0 | 130.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
13.0 | 39.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
13.0 | 65.2 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
13.0 | 117.3 | GO:0060074 | synapse maturation(GO:0060074) |
12.9 | 155.3 | GO:0016322 | neuron remodeling(GO:0016322) |
12.9 | 51.6 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
12.9 | 38.7 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
12.9 | 51.5 | GO:0034334 | adherens junction maintenance(GO:0034334) |
12.8 | 38.4 | GO:1902222 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
12.8 | 128.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
12.8 | 153.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
12.7 | 153.0 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
12.7 | 165.6 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
12.7 | 38.1 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
12.7 | 50.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
12.6 | 63.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
12.6 | 12.6 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
12.6 | 37.8 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
12.6 | 50.3 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
12.5 | 87.6 | GO:1902414 | protein localization to cell junction(GO:1902414) |
12.5 | 87.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
12.4 | 161.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
12.4 | 74.5 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) |
12.4 | 24.8 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
12.4 | 24.8 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
12.4 | 123.8 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
12.4 | 37.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
12.3 | 24.7 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
12.3 | 123.2 | GO:0060831 | smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:0060831) |
12.2 | 36.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
12.2 | 12.2 | GO:1904045 | cellular response to aldosterone(GO:1904045) |
12.2 | 85.6 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
12.2 | 48.9 | GO:0032288 | myelin assembly(GO:0032288) |
12.2 | 36.6 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
12.2 | 24.3 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
12.1 | 24.3 | GO:0072714 | response to selenite ion(GO:0072714) |
12.1 | 12.1 | GO:0009758 | carbohydrate utilization(GO:0009758) |
12.1 | 12.1 | GO:0035799 | ureter maturation(GO:0035799) |
12.1 | 48.4 | GO:0031642 | negative regulation of myelination(GO:0031642) |
12.1 | 12.1 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
12.1 | 48.4 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
12.1 | 48.3 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
12.1 | 48.3 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
12.1 | 60.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
12.1 | 132.7 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
12.1 | 12.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
12.0 | 83.9 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
11.9 | 143.0 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
11.9 | 11.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
11.9 | 35.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
11.9 | 23.7 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
11.9 | 11.9 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
11.8 | 1159.4 | GO:0007416 | synapse assembly(GO:0007416) |
11.8 | 35.5 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
11.8 | 35.5 | GO:0042357 | thiamine diphosphate metabolic process(GO:0042357) |
11.8 | 23.6 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
11.8 | 967.2 | GO:0007269 | neurotransmitter secretion(GO:0007269) signal release from synapse(GO:0099643) |
11.8 | 23.6 | GO:0071298 | cellular response to L-ascorbic acid(GO:0071298) |
11.8 | 35.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
11.7 | 81.8 | GO:0099504 | synaptic vesicle cycle(GO:0099504) |
11.7 | 11.7 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
11.7 | 93.4 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
11.6 | 23.2 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
11.6 | 242.9 | GO:0098926 | postsynaptic signal transduction(GO:0098926) |
11.5 | 34.6 | GO:0021816 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
11.5 | 69.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
11.4 | 34.3 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
11.4 | 57.1 | GO:0019563 | glycerol catabolic process(GO:0019563) |
11.4 | 11.4 | GO:0008038 | neuron recognition(GO:0008038) |
11.4 | 22.7 | GO:0052564 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
11.3 | 11.3 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
11.3 | 45.2 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
11.3 | 350.1 | GO:0015991 | ATP hydrolysis coupled proton transport(GO:0015991) |
11.2 | 11.2 | GO:0014821 | phasic smooth muscle contraction(GO:0014821) |
11.2 | 33.6 | GO:0099558 | maintenance of postsynaptic specialization structure(GO:0098880) maintenance of synapse structure(GO:0099558) maintenance of postsynaptic density structure(GO:0099562) |
11.2 | 11.2 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
11.2 | 89.4 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
11.1 | 111.0 | GO:0001573 | ganglioside metabolic process(GO:0001573) |
11.0 | 44.0 | GO:0044691 | tooth eruption(GO:0044691) |
11.0 | 33.0 | GO:0001755 | neural crest cell migration(GO:0001755) |
11.0 | 11.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
10.9 | 21.9 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
10.9 | 54.7 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
10.9 | 43.7 | GO:0007525 | somatic muscle development(GO:0007525) |
10.9 | 54.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
10.9 | 10.9 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
10.8 | 65.1 | GO:0045760 | positive regulation of action potential(GO:0045760) |
10.8 | 43.1 | GO:0048252 | lauric acid metabolic process(GO:0048252) |
10.8 | 118.5 | GO:1903671 | negative regulation of sprouting angiogenesis(GO:1903671) |
10.7 | 32.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
10.7 | 10.7 | GO:0072189 | ureter development(GO:0072189) |
10.7 | 32.2 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
10.7 | 42.8 | GO:0042417 | dopamine metabolic process(GO:0042417) |
10.7 | 32.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
10.6 | 63.9 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
10.6 | 95.8 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
10.6 | 42.4 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
10.6 | 10.6 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
10.6 | 31.8 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
10.6 | 53.0 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
10.6 | 84.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
10.6 | 31.8 | GO:0035912 | dorsal aorta morphogenesis(GO:0035912) |
10.6 | 73.9 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
10.5 | 21.0 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
10.5 | 31.5 | GO:0061588 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
10.5 | 325.3 | GO:0060291 | long-term synaptic potentiation(GO:0060291) |
10.5 | 52.4 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
10.5 | 31.4 | GO:0038031 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
10.5 | 83.7 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
10.5 | 10.5 | GO:0033076 | isoquinoline alkaloid metabolic process(GO:0033076) |
10.4 | 10.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
10.4 | 41.7 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
10.4 | 41.4 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
10.4 | 72.5 | GO:0000103 | sulfate assimilation(GO:0000103) |
10.4 | 41.4 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
10.4 | 31.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
10.3 | 62.1 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
10.3 | 31.0 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
10.3 | 72.4 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
10.3 | 31.0 | GO:0006742 | NADP catabolic process(GO:0006742) |
10.3 | 20.5 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
10.3 | 20.5 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
10.2 | 102.3 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
10.2 | 30.7 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
10.2 | 10.2 | GO:1902994 | negative regulation of beta-amyloid formation(GO:1902430) regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
10.2 | 122.6 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
10.2 | 81.6 | GO:0015884 | folic acid transport(GO:0015884) |
10.2 | 10.2 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
10.2 | 20.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
10.2 | 40.7 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
10.1 | 110.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
10.1 | 120.8 | GO:0030800 | negative regulation of cyclic nucleotide metabolic process(GO:0030800) |
10.1 | 40.2 | GO:0086018 | SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
10.0 | 30.1 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
10.0 | 30.1 | GO:0015688 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
10.0 | 20.0 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
10.0 | 10.0 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
10.0 | 99.9 | GO:0070327 | thyroid hormone transport(GO:0070327) |
10.0 | 69.9 | GO:0031643 | positive regulation of myelination(GO:0031643) |
10.0 | 39.9 | GO:0048143 | astrocyte activation(GO:0048143) |
9.9 | 29.7 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
9.9 | 108.8 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
9.9 | 9.9 | GO:0071888 | macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
9.9 | 19.8 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
9.9 | 78.9 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
9.9 | 39.4 | GO:1904426 | positive regulation of GTP binding(GO:1904426) |
9.8 | 29.5 | GO:0099612 | protein localization to axon(GO:0099612) |
9.8 | 68.8 | GO:2000169 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
9.8 | 39.3 | GO:0035524 | proline transmembrane transport(GO:0035524) |
9.8 | 19.6 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
9.8 | 58.8 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
9.8 | 29.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
9.8 | 19.6 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
9.8 | 9.8 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
9.7 | 97.4 | GO:0032933 | SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
9.7 | 29.2 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
9.7 | 145.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
9.7 | 9.7 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
9.7 | 9.7 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
9.7 | 19.4 | GO:0032230 | positive regulation of synaptic transmission, GABAergic(GO:0032230) |
9.7 | 19.3 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
9.7 | 38.6 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
9.7 | 86.9 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
9.6 | 9.6 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
9.6 | 48.1 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
9.6 | 28.9 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
9.6 | 28.8 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
9.6 | 38.3 | GO:0001964 | startle response(GO:0001964) |
9.6 | 38.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
9.6 | 67.0 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
9.5 | 9.5 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
9.5 | 9.5 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
9.5 | 28.4 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
9.5 | 47.3 | GO:0071318 | cellular response to ATP(GO:0071318) |
9.5 | 37.8 | GO:0015888 | thiamine transport(GO:0015888) |
9.4 | 18.9 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
9.4 | 9.4 | GO:1901020 | negative regulation of calcium ion transmembrane transporter activity(GO:1901020) |
9.4 | 18.8 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
9.4 | 18.8 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
9.3 | 55.9 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
9.3 | 18.6 | GO:0018410 | C-terminal protein amino acid modification(GO:0018410) |
9.3 | 9.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
9.3 | 9.3 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
9.3 | 27.8 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
9.2 | 18.5 | GO:0060426 | lung vasculature development(GO:0060426) |
9.2 | 27.6 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
9.2 | 27.6 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
9.2 | 27.6 | GO:0070831 | basement membrane assembly(GO:0070831) |
9.2 | 55.2 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
9.2 | 110.2 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
9.2 | 36.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
9.2 | 110.0 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
9.1 | 45.7 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) |
9.1 | 27.3 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
9.1 | 218.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
9.1 | 36.4 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
9.1 | 63.4 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
9.0 | 63.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
9.0 | 18.0 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
9.0 | 9.0 | GO:0014891 | striated muscle atrophy(GO:0014891) |
9.0 | 98.6 | GO:0045475 | locomotor rhythm(GO:0045475) |
9.0 | 9.0 | GO:0010958 | regulation of amino acid import(GO:0010958) |
8.9 | 259.5 | GO:0007026 | negative regulation of microtubule depolymerization(GO:0007026) |
8.9 | 26.8 | GO:0030043 | actin filament fragmentation(GO:0030043) |
8.9 | 8.9 | GO:0048371 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
8.9 | 8.9 | GO:1901185 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
8.9 | 98.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
8.9 | 142.4 | GO:0019236 | response to pheromone(GO:0019236) |
8.9 | 8.9 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
8.9 | 44.4 | GO:0048104 | establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
8.9 | 17.7 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
8.9 | 53.2 | GO:0014002 | astrocyte development(GO:0014002) |
8.8 | 35.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
8.8 | 17.6 | GO:0019614 | octopamine biosynthetic process(GO:0006589) catechol-containing compound catabolic process(GO:0019614) dopamine catabolic process(GO:0042420) catecholamine catabolic process(GO:0042424) octopamine metabolic process(GO:0046333) |
8.8 | 26.4 | GO:2000688 | positive regulation of rubidium ion transport(GO:2000682) positive regulation of rubidium ion transmembrane transporter activity(GO:2000688) |
8.8 | 44.1 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
8.8 | 17.6 | GO:0033483 | gas homeostasis(GO:0033483) |
8.7 | 17.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
8.7 | 34.9 | GO:0001552 | ovarian follicle atresia(GO:0001552) |
8.7 | 8.7 | GO:1904616 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
8.7 | 8.7 | GO:0072248 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
8.7 | 199.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
8.6 | 34.5 | GO:0042756 | drinking behavior(GO:0042756) |
8.6 | 25.9 | GO:0060988 | lipid tube assembly(GO:0060988) |
8.6 | 8.6 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
8.6 | 8.6 | GO:0071265 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
8.6 | 17.2 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
8.6 | 77.2 | GO:1900025 | negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
8.6 | 17.1 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
8.6 | 17.1 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
8.6 | 51.4 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
8.6 | 25.7 | GO:0070314 | G1 to G0 transition(GO:0070314) |
8.6 | 213.8 | GO:1901379 | regulation of potassium ion transmembrane transport(GO:1901379) |
8.5 | 8.5 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
8.5 | 8.5 | GO:0002397 | MHC class I protein complex assembly(GO:0002397) |
8.5 | 25.5 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
8.5 | 17.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) pilomotor reflex(GO:0097195) |
8.5 | 8.5 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
8.5 | 8.5 | GO:0050957 | equilibrioception(GO:0050957) |
8.5 | 161.3 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
8.5 | 42.4 | GO:0070459 | prolactin secretion(GO:0070459) |
8.5 | 25.4 | GO:0060346 | bone trabecula formation(GO:0060346) |
8.5 | 16.9 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
8.5 | 8.5 | GO:0051795 | positive regulation of catagen(GO:0051795) |
8.4 | 33.8 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
8.4 | 33.7 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) |
8.4 | 58.9 | GO:0006465 | signal peptide processing(GO:0006465) |
8.4 | 8.4 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
8.4 | 192.9 | GO:0048168 | regulation of neuronal synaptic plasticity(GO:0048168) |
8.4 | 25.1 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
8.4 | 16.7 | GO:0010635 | regulation of mitochondrial fusion(GO:0010635) |
8.4 | 25.1 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
8.3 | 50.1 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
8.3 | 16.6 | GO:0042427 | serotonin biosynthetic process(GO:0042427) primary amino compound biosynthetic process(GO:1901162) |
8.3 | 74.7 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
8.3 | 198.5 | GO:0008542 | visual learning(GO:0008542) |
8.3 | 8.3 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
8.3 | 57.9 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
8.3 | 49.6 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
8.2 | 33.0 | GO:0060023 | soft palate development(GO:0060023) |
8.2 | 16.4 | GO:0006116 | NADH oxidation(GO:0006116) |
8.2 | 147.4 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
8.2 | 8.2 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
8.2 | 8.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
8.2 | 48.9 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
8.1 | 16.2 | GO:0070296 | sarcoplasmic reticulum calcium ion transport(GO:0070296) |
8.1 | 16.2 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
8.1 | 8.1 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
8.1 | 8.1 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
8.1 | 56.4 | GO:0051182 | coenzyme transport(GO:0051182) |
8.0 | 24.0 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
8.0 | 8.0 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
8.0 | 8.0 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
7.9 | 23.8 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
7.9 | 15.8 | GO:0071313 | cellular response to caffeine(GO:0071313) |
7.9 | 39.6 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
7.9 | 15.8 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
7.9 | 23.7 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
7.9 | 23.6 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
7.8 | 78.3 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
7.8 | 39.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
7.8 | 109.0 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
7.8 | 653.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
7.8 | 15.5 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
7.8 | 7.8 | GO:0098598 | learned vocalization behavior or vocal learning(GO:0098598) |
7.7 | 85.1 | GO:0006688 | glycosphingolipid biosynthetic process(GO:0006688) |
7.7 | 7.7 | GO:0061740 | protein targeting to lysosome involved in chaperone-mediated autophagy(GO:0061740) |
7.7 | 15.4 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
7.7 | 53.8 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
7.7 | 15.3 | GO:0046684 | response to pyrethroid(GO:0046684) |
7.7 | 38.3 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
7.7 | 38.3 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
7.7 | 7.7 | GO:0014047 | glutamate secretion(GO:0014047) |
7.6 | 91.7 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
7.6 | 38.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
7.6 | 45.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
7.6 | 7.6 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
7.6 | 30.4 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
7.6 | 15.2 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
7.6 | 7.6 | GO:0007041 | lysosomal transport(GO:0007041) |
7.6 | 22.7 | GO:0089709 | histidine transport(GO:0015817) L-histidine transmembrane transport(GO:0089709) L-histidine transport(GO:1902024) |
7.6 | 15.1 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
7.6 | 15.1 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
7.5 | 7.5 | GO:0018307 | enzyme active site formation(GO:0018307) |
7.5 | 7.5 | GO:0072048 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
7.5 | 7.5 | GO:0010611 | regulation of cardiac muscle hypertrophy(GO:0010611) |
7.5 | 67.3 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
7.5 | 22.4 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
7.4 | 22.3 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
7.4 | 111.4 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
7.4 | 44.6 | GO:0030953 | astral microtubule organization(GO:0030953) |
7.4 | 22.2 | GO:1900078 | positive regulation of cellular response to insulin stimulus(GO:1900078) |
7.4 | 7.4 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
7.4 | 29.5 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
7.4 | 14.8 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
7.4 | 36.9 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
7.4 | 29.5 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
7.4 | 22.1 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
7.4 | 14.7 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
7.4 | 14.7 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
7.4 | 7.4 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
7.3 | 14.7 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
7.3 | 58.7 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
7.3 | 117.0 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
7.3 | 80.4 | GO:0009629 | response to gravity(GO:0009629) |
7.3 | 43.8 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
7.3 | 29.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
7.3 | 21.9 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
7.3 | 43.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
7.3 | 29.1 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
7.3 | 21.8 | GO:0051036 | regulation of endosome size(GO:0051036) |
7.3 | 29.0 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
7.2 | 101.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
7.2 | 28.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
7.2 | 7.2 | GO:0036115 | fatty-acyl-CoA catabolic process(GO:0036115) |
7.2 | 21.6 | GO:0032474 | otolith morphogenesis(GO:0032474) |
7.2 | 36.0 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
7.2 | 28.7 | GO:0019042 | viral latency(GO:0019042) release from viral latency(GO:0019046) |
7.2 | 14.3 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
7.2 | 64.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
7.1 | 49.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
7.1 | 64.0 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
7.1 | 35.5 | GO:0010447 | response to acidic pH(GO:0010447) |
7.1 | 14.2 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
7.1 | 14.1 | GO:0071000 | response to magnetism(GO:0071000) |
7.1 | 226.2 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
7.1 | 240.1 | GO:0022900 | electron transport chain(GO:0022900) |
7.1 | 120.0 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
7.1 | 28.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
7.1 | 14.1 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
7.0 | 7.0 | GO:0033275 | actin-myosin filament sliding(GO:0033275) |
7.0 | 21.1 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
7.0 | 217.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
7.0 | 21.0 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
7.0 | 21.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
7.0 | 7.0 | GO:2000157 | regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
7.0 | 7.0 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
6.9 | 97.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
6.9 | 13.9 | GO:0048243 | norepinephrine secretion(GO:0048243) |
6.9 | 6.9 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
6.9 | 34.6 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
6.9 | 20.7 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
6.9 | 20.7 | GO:0021542 | dentate gyrus development(GO:0021542) |
6.9 | 34.4 | GO:0051122 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
6.9 | 20.6 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
6.8 | 20.5 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
6.8 | 47.6 | GO:0042407 | cristae formation(GO:0042407) |
6.8 | 13.6 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
6.8 | 197.0 | GO:0021762 | substantia nigra development(GO:0021762) |
6.8 | 94.9 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
6.8 | 13.5 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
6.8 | 54.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
6.8 | 27.1 | GO:0031585 | regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031585) |
6.8 | 6.8 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
6.7 | 6.7 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
6.7 | 20.2 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
6.7 | 33.7 | GO:0048484 | enteric nervous system development(GO:0048484) |
6.7 | 6.7 | GO:0060166 | olfactory pit development(GO:0060166) |
6.7 | 20.2 | GO:1902730 | positive regulation of proteoglycan biosynthetic process(GO:1902730) |
6.7 | 20.2 | GO:0060536 | cartilage morphogenesis(GO:0060536) |
6.7 | 6.7 | GO:0042069 | regulation of catecholamine metabolic process(GO:0042069) |
6.7 | 33.5 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
6.7 | 107.2 | GO:0030501 | positive regulation of bone mineralization(GO:0030501) |
6.7 | 33.5 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
6.7 | 6.7 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
6.6 | 13.3 | GO:0039019 | pronephric nephron development(GO:0039019) |
6.6 | 19.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
6.6 | 6.6 | GO:0006649 | phospholipid transfer to membrane(GO:0006649) |
6.6 | 6.6 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
6.6 | 6.6 | GO:0089718 | amino acid import across plasma membrane(GO:0089718) |
6.6 | 65.8 | GO:2001014 | regulation of skeletal muscle cell differentiation(GO:2001014) |
6.6 | 32.8 | GO:0002934 | desmosome organization(GO:0002934) |
6.6 | 19.7 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) |
6.5 | 32.7 | GO:0006089 | lactate metabolic process(GO:0006089) |
6.5 | 65.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
6.5 | 319.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
6.5 | 45.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
6.5 | 6.5 | GO:1990523 | bone regeneration(GO:1990523) |
6.5 | 39.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
6.5 | 13.0 | GO:0009820 | alkaloid metabolic process(GO:0009820) |
6.5 | 39.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
6.5 | 32.5 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
6.5 | 19.4 | GO:0019086 | late viral transcription(GO:0019086) |
6.4 | 12.9 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
6.4 | 19.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
6.4 | 12.8 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
6.4 | 12.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
6.4 | 25.6 | GO:0055075 | potassium ion homeostasis(GO:0055075) |
6.4 | 12.8 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
6.4 | 19.2 | GO:0060180 | female mating behavior(GO:0060180) |
6.4 | 6.4 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
6.4 | 31.9 | GO:0015889 | cobalamin transport(GO:0015889) |
6.4 | 38.3 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
6.4 | 101.9 | GO:0050650 | chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
6.4 | 19.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
6.4 | 19.1 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
6.3 | 6.3 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
6.3 | 19.0 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
6.3 | 19.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
6.3 | 62.9 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
6.3 | 6.3 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
6.3 | 25.1 | GO:0014854 | response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
6.3 | 12.6 | GO:0072014 | proximal tubule development(GO:0072014) |
6.3 | 118.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
6.2 | 37.5 | GO:0015074 | DNA integration(GO:0015074) |
6.2 | 24.9 | GO:1990403 | embryonic brain development(GO:1990403) |
6.2 | 62.2 | GO:0071786 | endoplasmic reticulum tubular network organization(GO:0071786) |
6.2 | 12.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
6.2 | 12.4 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
6.2 | 68.1 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
6.2 | 12.3 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
6.1 | 36.8 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
6.1 | 18.4 | GO:0051031 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
6.1 | 12.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
6.1 | 6.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
6.1 | 48.7 | GO:0021794 | thalamus development(GO:0021794) |
6.1 | 12.2 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
6.1 | 54.7 | GO:0040036 | regulation of fibroblast growth factor receptor signaling pathway(GO:0040036) |
6.1 | 121.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
6.1 | 78.9 | GO:0021860 | pyramidal neuron development(GO:0021860) |
6.1 | 18.2 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
6.1 | 48.5 | GO:0097369 | sodium ion import(GO:0097369) |
6.1 | 18.2 | GO:0042133 | neurotransmitter metabolic process(GO:0042133) |
6.1 | 48.4 | GO:0035754 | B cell chemotaxis(GO:0035754) |
6.0 | 78.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
6.0 | 60.4 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
6.0 | 12.1 | GO:0015791 | polyol transport(GO:0015791) |
6.0 | 12.1 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
6.0 | 6.0 | GO:0019521 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
6.0 | 24.1 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
6.0 | 24.1 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
6.0 | 102.3 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
6.0 | 24.0 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
6.0 | 185.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
6.0 | 29.9 | GO:0003096 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
5.9 | 23.8 | GO:0060347 | heart trabecula formation(GO:0060347) |
5.9 | 41.3 | GO:0035418 | protein localization to synapse(GO:0035418) |
5.9 | 5.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
5.9 | 17.7 | GO:0032377 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
5.9 | 41.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
5.9 | 11.7 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
5.9 | 52.8 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
5.8 | 11.6 | GO:0042335 | cuticle development(GO:0042335) |
5.8 | 46.5 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
5.8 | 23.2 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
5.8 | 104.5 | GO:0030239 | myofibril assembly(GO:0030239) |
5.8 | 17.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
5.8 | 17.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
5.8 | 115.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
5.7 | 40.2 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
5.7 | 17.2 | GO:1903541 | regulation of exosomal secretion(GO:1903541) |
5.7 | 5.7 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
5.7 | 40.1 | GO:0031110 | regulation of microtubule polymerization or depolymerization(GO:0031110) |
5.7 | 5.7 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
5.7 | 11.4 | GO:0006565 | L-serine catabolic process(GO:0006565) |
5.7 | 11.4 | GO:0035412 | regulation of catenin import into nucleus(GO:0035412) |
5.7 | 34.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
5.7 | 5.7 | GO:0042311 | vasodilation(GO:0042311) |
5.7 | 34.1 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
5.7 | 5.7 | GO:2000275 | regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
5.7 | 186.8 | GO:0046839 | phospholipid dephosphorylation(GO:0046839) |
5.7 | 5.7 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
5.6 | 28.2 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
5.6 | 33.9 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
5.6 | 22.6 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
5.6 | 366.2 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
5.6 | 28.1 | GO:0042670 | retinal cone cell differentiation(GO:0042670) |
5.6 | 218.1 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
5.6 | 22.3 | GO:0045792 | negative regulation of cell size(GO:0045792) |
5.6 | 72.3 | GO:0006836 | neurotransmitter transport(GO:0006836) |
5.6 | 16.7 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
5.6 | 22.2 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
5.5 | 5.5 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
5.5 | 5.5 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
5.5 | 5.5 | GO:0061517 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) |
5.5 | 16.6 | GO:1990402 | embryonic liver development(GO:1990402) |
5.5 | 22.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
5.5 | 11.0 | GO:0001505 | regulation of neurotransmitter levels(GO:0001505) |
5.5 | 21.8 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
5.5 | 27.3 | GO:0061709 | reticulophagy(GO:0061709) |
5.4 | 5.4 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
5.4 | 10.9 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
5.4 | 16.3 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
5.4 | 16.3 | GO:1903999 | negative regulation of eating behavior(GO:1903999) |
5.4 | 16.2 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
5.4 | 10.8 | GO:0090131 | mesenchyme migration(GO:0090131) |
5.4 | 59.5 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
5.4 | 27.0 | GO:0042048 | olfactory behavior(GO:0042048) |
5.4 | 5.4 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
5.4 | 32.4 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
5.4 | 5.4 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
5.4 | 58.9 | GO:0010842 | retina layer formation(GO:0010842) |
5.4 | 10.7 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
5.4 | 32.1 | GO:0001967 | suckling behavior(GO:0001967) |
5.4 | 5.4 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
5.3 | 5.3 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
5.3 | 21.3 | GO:0036337 | Fas signaling pathway(GO:0036337) |
5.3 | 10.6 | GO:0051546 | keratinocyte migration(GO:0051546) |
5.3 | 47.7 | GO:0014850 | response to muscle activity(GO:0014850) |
5.3 | 37.0 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
5.3 | 10.6 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
5.3 | 5.3 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
5.3 | 26.4 | GO:0032099 | negative regulation of appetite(GO:0032099) |
5.3 | 26.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
5.2 | 73.2 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
5.2 | 15.7 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
5.2 | 20.8 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
5.2 | 31.2 | GO:0010771 | negative regulation of cell morphogenesis involved in differentiation(GO:0010771) |
5.2 | 15.6 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
5.2 | 20.8 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
5.2 | 5.2 | GO:0072124 | regulation of glomerular mesangial cell proliferation(GO:0072124) |
5.1 | 20.6 | GO:0006524 | alanine catabolic process(GO:0006524) pyruvate family amino acid catabolic process(GO:0009080) L-alanine catabolic process(GO:0042853) |
5.1 | 10.3 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
5.1 | 5.1 | GO:0048014 | Tie signaling pathway(GO:0048014) |
5.1 | 10.3 | GO:0033575 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
5.1 | 15.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
5.1 | 91.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
5.1 | 132.3 | GO:0046785 | microtubule polymerization(GO:0046785) |
5.1 | 50.7 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
5.1 | 10.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
5.0 | 10.1 | GO:0035973 | aggrephagy(GO:0035973) |
5.0 | 10.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
5.0 | 25.1 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
5.0 | 5.0 | GO:0097479 | synaptic vesicle localization(GO:0097479) |
5.0 | 5.0 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) |
5.0 | 39.9 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
5.0 | 10.0 | GO:0070141 | response to UV-A(GO:0070141) |
5.0 | 49.7 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
5.0 | 9.9 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
5.0 | 44.7 | GO:0016540 | protein autoprocessing(GO:0016540) |
5.0 | 9.9 | GO:0030186 | melatonin metabolic process(GO:0030186) |
5.0 | 113.9 | GO:0007612 | learning(GO:0007612) |
5.0 | 14.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
4.9 | 14.8 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
4.9 | 4.9 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
4.9 | 9.8 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
4.9 | 4.9 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
4.9 | 14.7 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
4.9 | 68.4 | GO:0046697 | decidualization(GO:0046697) |
4.9 | 19.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
4.9 | 24.3 | GO:0010193 | response to ozone(GO:0010193) |
4.9 | 4.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
4.8 | 58.0 | GO:0042737 | drug catabolic process(GO:0042737) |
4.8 | 4.8 | GO:0032530 | regulation of microvillus organization(GO:0032530) |
4.8 | 14.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
4.8 | 48.1 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
4.8 | 14.4 | GO:0051350 | negative regulation of lyase activity(GO:0051350) |
4.8 | 47.9 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
4.8 | 24.0 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
4.8 | 19.2 | GO:1904823 | purine nucleobase transmembrane transport(GO:1904823) |
4.8 | 9.5 | GO:0035994 | response to muscle stretch(GO:0035994) |
4.8 | 9.5 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
4.7 | 28.5 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
4.7 | 18.9 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
4.7 | 9.4 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
4.7 | 4.7 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
4.7 | 4.7 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
4.7 | 14.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
4.7 | 51.6 | GO:0014003 | oligodendrocyte development(GO:0014003) |
4.6 | 13.9 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
4.6 | 13.9 | GO:0031989 | bombesin receptor signaling pathway(GO:0031989) |
4.6 | 4.6 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
4.6 | 4.6 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
4.6 | 36.9 | GO:0006865 | amino acid transport(GO:0006865) |
4.6 | 13.8 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
4.6 | 41.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
4.6 | 4.6 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
4.6 | 9.1 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
4.6 | 13.7 | GO:0015874 | norepinephrine transport(GO:0015874) |
4.5 | 13.6 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
4.5 | 4.5 | GO:0048102 | autophagic cell death(GO:0048102) |
4.5 | 13.6 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
4.5 | 13.6 | GO:0002084 | protein depalmitoylation(GO:0002084) |
4.5 | 9.0 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
4.5 | 112.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
4.5 | 18.0 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
4.5 | 22.5 | GO:0048539 | bone marrow development(GO:0048539) |
4.5 | 13.5 | GO:0010996 | response to auditory stimulus(GO:0010996) |
4.5 | 9.0 | GO:1904382 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) glycoprotein ERAD pathway(GO:0097466) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
4.5 | 22.4 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
4.5 | 31.4 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
4.5 | 35.8 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
4.5 | 40.3 | GO:0007000 | nucleolus organization(GO:0007000) |
4.5 | 8.9 | GO:0072592 | oxygen metabolic process(GO:0072592) |
4.5 | 13.4 | GO:0016598 | protein arginylation(GO:0016598) |
4.5 | 17.8 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
4.4 | 13.3 | GO:0072311 | renal filtration cell differentiation(GO:0061318) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
4.4 | 4.4 | GO:0070541 | response to platinum ion(GO:0070541) |
4.4 | 17.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
4.4 | 13.2 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
4.4 | 4.4 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
4.4 | 4.4 | GO:0009405 | pathogenesis(GO:0009405) |
4.4 | 13.2 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
4.4 | 8.8 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
4.4 | 131.2 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
4.4 | 8.7 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
4.3 | 8.7 | GO:0006983 | ER overload response(GO:0006983) |
4.3 | 25.9 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
4.3 | 17.3 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
4.3 | 4.3 | GO:0051956 | negative regulation of amino acid transport(GO:0051956) |
4.3 | 30.1 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
4.3 | 12.9 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
4.3 | 17.1 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
4.3 | 4.3 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
4.3 | 4.3 | GO:0072425 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
4.3 | 59.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
4.3 | 8.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
4.3 | 17.1 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
4.3 | 25.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
4.2 | 4.2 | GO:0071569 | protein ufmylation(GO:0071569) |
4.2 | 8.5 | GO:1903121 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
4.2 | 17.0 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
4.2 | 8.5 | GO:0016488 | sesquiterpenoid catabolic process(GO:0016107) farnesol metabolic process(GO:0016487) farnesol catabolic process(GO:0016488) |
4.2 | 4.2 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
4.2 | 8.4 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
4.2 | 46.3 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
4.2 | 80.0 | GO:0010761 | fibroblast migration(GO:0010761) |
4.2 | 12.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
4.2 | 21.0 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
4.2 | 277.1 | GO:0071805 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
4.2 | 8.4 | GO:0032258 | CVT pathway(GO:0032258) |
4.2 | 8.4 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
4.2 | 20.9 | GO:0021799 | cerebral cortex radially oriented cell migration(GO:0021799) |
4.2 | 104.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
4.2 | 29.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
4.2 | 16.7 | GO:1903297 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
4.2 | 24.9 | GO:0016264 | gap junction assembly(GO:0016264) |
4.1 | 8.3 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
4.1 | 8.3 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
4.1 | 4.1 | GO:0060438 | trachea development(GO:0060438) |
4.1 | 33.0 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
4.1 | 4.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
4.1 | 8.2 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
4.1 | 20.5 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
4.1 | 16.3 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
4.1 | 20.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
4.1 | 8.2 | GO:0021554 | optic nerve development(GO:0021554) |
4.1 | 8.2 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
4.1 | 16.3 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
4.1 | 12.2 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
4.0 | 40.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
4.0 | 32.0 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
4.0 | 8.0 | GO:0030035 | microspike assembly(GO:0030035) |
4.0 | 8.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
4.0 | 31.7 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
3.9 | 55.3 | GO:0006829 | zinc II ion transport(GO:0006829) |
3.9 | 3.9 | GO:0045794 | negative regulation of cell volume(GO:0045794) |
3.9 | 7.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
3.9 | 141.9 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
3.9 | 15.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
3.9 | 19.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
3.9 | 23.5 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
3.9 | 11.7 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
3.9 | 3.9 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
3.9 | 19.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
3.9 | 19.3 | GO:0009414 | response to water deprivation(GO:0009414) |
3.8 | 3.8 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
3.8 | 3.8 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
3.8 | 3.8 | GO:0042045 | epithelial fluid transport(GO:0042045) |
3.8 | 11.4 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
3.8 | 18.9 | GO:0023021 | termination of signal transduction(GO:0023021) |
3.8 | 26.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
3.8 | 18.8 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
3.8 | 11.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
3.7 | 3.7 | GO:0003383 | apical constriction(GO:0003383) |
3.7 | 3.7 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
3.7 | 18.7 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
3.7 | 3.7 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
3.7 | 11.2 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
3.7 | 11.2 | GO:0009597 | detection of virus(GO:0009597) |
3.7 | 18.6 | GO:0008347 | glial cell migration(GO:0008347) |
3.7 | 3.7 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
3.7 | 22.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
3.7 | 47.9 | GO:0099518 | vesicle cytoskeletal trafficking(GO:0099518) |
3.7 | 73.7 | GO:0018345 | protein palmitoylation(GO:0018345) |
3.7 | 18.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
3.6 | 7.3 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
3.6 | 10.9 | GO:0038158 | granulocyte colony-stimulating factor signaling pathway(GO:0038158) |
3.6 | 256.6 | GO:0006814 | sodium ion transport(GO:0006814) |
3.6 | 10.7 | GO:0031053 | primary miRNA processing(GO:0031053) |
3.6 | 35.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
3.6 | 32.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
3.5 | 7.1 | GO:0098901 | regulation of cardiac muscle cell action potential(GO:0098901) |
3.5 | 109.8 | GO:0035773 | insulin secretion involved in cellular response to glucose stimulus(GO:0035773) |
3.5 | 7.0 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
3.5 | 10.5 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
3.5 | 31.5 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
3.5 | 7.0 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
3.5 | 13.9 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
3.5 | 13.9 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
3.5 | 17.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
3.5 | 6.9 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
3.5 | 31.2 | GO:0006903 | vesicle targeting(GO:0006903) |
3.5 | 6.9 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
3.5 | 10.4 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
3.5 | 6.9 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
3.4 | 24.1 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
3.4 | 3.4 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
3.4 | 20.6 | GO:0060723 | regulation of spongiotrophoblast cell proliferation(GO:0060721) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
3.4 | 10.3 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
3.4 | 10.2 | GO:0001709 | cell fate determination(GO:0001709) |
3.4 | 3.4 | GO:0010746 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) |
3.4 | 10.2 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
3.4 | 111.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
3.4 | 6.8 | GO:0044597 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
3.4 | 16.9 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
3.4 | 33.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
3.4 | 23.5 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
3.3 | 10.0 | GO:0019417 | sulfur oxidation(GO:0019417) |
3.3 | 13.4 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
3.3 | 26.7 | GO:0097352 | autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
3.3 | 6.7 | GO:0034214 | protein hexamerization(GO:0034214) |
3.3 | 10.0 | GO:0036481 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) |
3.3 | 3.3 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
3.3 | 3.3 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
3.3 | 13.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
3.3 | 3.3 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
3.3 | 9.8 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
3.3 | 19.5 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
3.3 | 35.8 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
3.2 | 19.4 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
3.2 | 12.9 | GO:0055062 | phosphate ion homeostasis(GO:0055062) trivalent inorganic anion homeostasis(GO:0072506) |
3.2 | 6.4 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) |
3.2 | 12.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
3.2 | 3.2 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
3.2 | 9.6 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
3.2 | 6.4 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
3.2 | 101.6 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
3.2 | 6.3 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
3.2 | 15.9 | GO:0007097 | nuclear migration(GO:0007097) |
3.2 | 6.3 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
3.2 | 31.6 | GO:0000338 | protein deneddylation(GO:0000338) |
3.2 | 3.2 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
3.1 | 12.6 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
3.1 | 15.6 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
3.1 | 53.0 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
3.1 | 15.6 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
3.1 | 12.4 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
3.1 | 24.9 | GO:0007588 | excretion(GO:0007588) |
3.1 | 6.2 | GO:0043267 | negative regulation of potassium ion transport(GO:0043267) |
3.1 | 27.8 | GO:0032274 | gonadotropin secretion(GO:0032274) |
3.1 | 6.2 | GO:0018158 | protein oxidation(GO:0018158) |
3.1 | 9.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
3.1 | 18.4 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
3.0 | 9.1 | GO:0071442 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
3.0 | 15.2 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
3.0 | 3.0 | GO:0097119 | postsynaptic density protein 95 clustering(GO:0097119) |
3.0 | 69.9 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
3.0 | 15.1 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) |
3.0 | 18.0 | GO:0051593 | response to folic acid(GO:0051593) |
3.0 | 3.0 | GO:0051958 | methotrexate transport(GO:0051958) |
3.0 | 3.0 | GO:1990646 | cellular response to prolactin(GO:1990646) |
3.0 | 18.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
3.0 | 9.0 | GO:1900095 | random inactivation of X chromosome(GO:0060816) regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
3.0 | 17.9 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
3.0 | 14.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
3.0 | 14.8 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
3.0 | 3.0 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
3.0 | 20.7 | GO:1900746 | regulation of vascular endothelial growth factor signaling pathway(GO:1900746) |
2.9 | 8.8 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
2.9 | 17.5 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
2.9 | 2.9 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
2.9 | 2.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
2.9 | 52.2 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
2.9 | 8.6 | GO:0002076 | osteoblast development(GO:0002076) |
2.9 | 51.7 | GO:0006818 | hydrogen transport(GO:0006818) |
2.9 | 31.6 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
2.9 | 5.7 | GO:0051775 | response to redox state(GO:0051775) |
2.9 | 22.9 | GO:0046033 | AMP metabolic process(GO:0046033) |
2.9 | 37.2 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
2.8 | 8.5 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
2.8 | 5.7 | GO:0001927 | exocyst assembly(GO:0001927) |
2.8 | 16.9 | GO:0046834 | lipid phosphorylation(GO:0046834) |
2.8 | 14.1 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
2.8 | 5.6 | GO:0006566 | threonine metabolic process(GO:0006566) |
2.8 | 11.2 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
2.8 | 8.3 | GO:0048749 | compound eye development(GO:0048749) |
2.8 | 2.8 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
2.7 | 8.2 | GO:1903378 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
2.7 | 11.0 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
2.7 | 2.7 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
2.7 | 60.1 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
2.7 | 24.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
2.7 | 35.3 | GO:0008053 | mitochondrial fusion(GO:0008053) |
2.7 | 21.7 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
2.7 | 40.6 | GO:0061512 | protein localization to cilium(GO:0061512) |
2.7 | 13.5 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
2.7 | 8.1 | GO:0006835 | dicarboxylic acid transport(GO:0006835) |
2.7 | 10.7 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
2.7 | 5.3 | GO:0009609 | response to symbiotic bacterium(GO:0009609) |
2.7 | 2.7 | GO:0050932 | positive regulation of developmental pigmentation(GO:0048087) regulation of pigment cell differentiation(GO:0050932) positive regulation of pigment cell differentiation(GO:0050942) |
2.7 | 8.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
2.7 | 26.5 | GO:0045332 | phospholipid translocation(GO:0045332) |
2.6 | 5.3 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
2.6 | 2.6 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
2.6 | 2.6 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
2.6 | 47.1 | GO:0050808 | synapse organization(GO:0050808) |
2.6 | 5.2 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
2.6 | 7.8 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
2.6 | 5.2 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
2.6 | 10.4 | GO:1904908 | negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
2.6 | 12.9 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
2.6 | 20.6 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
2.6 | 5.2 | GO:0072720 | response to dithiothreitol(GO:0072720) |
2.6 | 5.1 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
2.6 | 15.3 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
2.6 | 7.7 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
2.5 | 17.8 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
2.5 | 20.3 | GO:0007032 | endosome organization(GO:0007032) |
2.5 | 2.5 | GO:1990379 | lipid transport across blood brain barrier(GO:1990379) |
2.5 | 12.6 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
2.5 | 7.5 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
2.5 | 52.7 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
2.5 | 7.5 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
2.5 | 17.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
2.5 | 17.5 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
2.5 | 7.5 | GO:0009249 | protein lipoylation(GO:0009249) |
2.5 | 5.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
2.5 | 7.5 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
2.5 | 5.0 | GO:1904970 | brush border assembly(GO:1904970) |
2.5 | 5.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
2.5 | 44.7 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
2.5 | 7.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
2.5 | 12.3 | GO:0042574 | retinal metabolic process(GO:0042574) |
2.4 | 4.9 | GO:0051204 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) protein insertion into mitochondrial membrane(GO:0051204) |
2.4 | 9.8 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
2.4 | 14.6 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
2.4 | 87.8 | GO:0006497 | protein lipidation(GO:0006497) |
2.4 | 145.8 | GO:0035308 | negative regulation of protein dephosphorylation(GO:0035308) |
2.4 | 2.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
2.4 | 9.6 | GO:0019483 | beta-alanine biosynthetic process(GO:0019483) |
2.4 | 38.3 | GO:0009251 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
2.4 | 4.8 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
2.4 | 2.4 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
2.4 | 7.2 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
2.4 | 9.5 | GO:1903525 | regulation of membrane tubulation(GO:1903525) positive regulation of membrane tubulation(GO:1903527) |
2.4 | 9.5 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
2.4 | 30.9 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
2.3 | 2.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
2.3 | 2.3 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
2.3 | 2.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
2.3 | 4.6 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
2.3 | 11.6 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
2.3 | 83.2 | GO:0030705 | cytoskeleton-dependent intracellular transport(GO:0030705) |
2.3 | 6.9 | GO:0033683 | nucleotide-excision repair, DNA incision(GO:0033683) |
2.3 | 2.3 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
2.3 | 36.8 | GO:0050879 | multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
2.3 | 9.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
2.3 | 2.3 | GO:0051030 | snRNA transport(GO:0051030) |
2.3 | 9.1 | GO:0045992 | negative regulation of embryonic development(GO:0045992) |
2.3 | 16.0 | GO:0050803 | regulation of synapse structure or activity(GO:0050803) |
2.3 | 11.3 | GO:0006751 | glutathione catabolic process(GO:0006751) |
2.3 | 9.0 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
2.3 | 4.5 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
2.2 | 4.5 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
2.2 | 11.2 | GO:0042026 | protein refolding(GO:0042026) |
2.2 | 15.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
2.2 | 2.2 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
2.2 | 8.8 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
2.2 | 15.4 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
2.2 | 2.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) phosphatidylglycerol metabolic process(GO:0046471) |
2.2 | 2.2 | GO:1903727 | positive regulation of phospholipid metabolic process(GO:1903727) |
2.2 | 4.3 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
2.2 | 121.0 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
2.1 | 2.1 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
2.1 | 2.1 | GO:0072530 | purine-containing compound transmembrane transport(GO:0072530) |
2.1 | 72.0 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
2.1 | 4.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
2.1 | 6.3 | GO:0060285 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
2.1 | 32.8 | GO:0003351 | epithelial cilium movement(GO:0003351) |
2.1 | 16.4 | GO:0060736 | prostate gland growth(GO:0060736) |
2.0 | 4.1 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
2.0 | 2.0 | GO:0035315 | hair cell differentiation(GO:0035315) |
2.0 | 10.1 | GO:0070417 | cellular response to cold(GO:0070417) |
2.0 | 8.1 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
2.0 | 10.0 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
2.0 | 2.0 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
2.0 | 11.9 | GO:0017121 | phospholipid scrambling(GO:0017121) |
2.0 | 4.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
2.0 | 5.9 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
2.0 | 90.7 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
1.9 | 9.7 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.9 | 3.8 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.9 | 28.8 | GO:0050905 | neuromuscular process(GO:0050905) |
1.9 | 13.4 | GO:0098930 | axonal transport(GO:0098930) |
1.9 | 19.2 | GO:1903391 | regulation of adherens junction organization(GO:1903391) |
1.9 | 1.9 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
1.9 | 1.9 | GO:0003091 | renal water homeostasis(GO:0003091) |
1.9 | 11.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
1.9 | 3.8 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
1.9 | 5.6 | GO:0032218 | riboflavin transport(GO:0032218) |
1.9 | 48.7 | GO:1905037 | autophagosome organization(GO:1905037) |
1.9 | 15.0 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
1.9 | 24.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
1.9 | 7.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
1.8 | 25.6 | GO:0016236 | macroautophagy(GO:0016236) |
1.8 | 3.7 | GO:0060463 | lung lobe morphogenesis(GO:0060463) |
1.8 | 7.3 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
1.8 | 5.4 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
1.8 | 25.2 | GO:0097503 | sialylation(GO:0097503) |
1.8 | 5.4 | GO:1902590 | viral budding via host ESCRT complex(GO:0039702) viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
1.8 | 23.4 | GO:0010269 | response to selenium ion(GO:0010269) |
1.8 | 12.6 | GO:0031103 | axon regeneration(GO:0031103) |
1.8 | 7.2 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
1.8 | 7.1 | GO:0016559 | peroxisome fission(GO:0016559) |
1.8 | 1.8 | GO:0009650 | UV protection(GO:0009650) |
1.8 | 8.8 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
1.7 | 5.2 | GO:0051013 | microtubule severing(GO:0051013) |
1.7 | 34.6 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
1.7 | 3.5 | GO:0016074 | snoRNA metabolic process(GO:0016074) |
1.7 | 20.6 | GO:0021696 | cerebellar cortex morphogenesis(GO:0021696) |
1.7 | 17.2 | GO:0001893 | maternal placenta development(GO:0001893) |
1.7 | 1.7 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
1.7 | 25.5 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
1.7 | 3.3 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
1.7 | 11.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
1.7 | 5.0 | GO:0042363 | fat-soluble vitamin catabolic process(GO:0042363) |
1.7 | 10.0 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
1.6 | 13.2 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
1.6 | 13.2 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
1.6 | 3.3 | GO:0006788 | heme oxidation(GO:0006788) |
1.6 | 60.6 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
1.6 | 4.9 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
1.6 | 17.8 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
1.6 | 3.2 | GO:0034372 | triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
1.6 | 3.2 | GO:0070586 | cell-cell adhesion involved in gastrulation(GO:0070586) |
1.6 | 6.4 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.6 | 1.6 | GO:0042245 | RNA repair(GO:0042245) |
1.6 | 19.0 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
1.6 | 1.6 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
1.6 | 3.1 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.5 | 4.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.5 | 1.5 | GO:0098705 | copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
1.5 | 6.1 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
1.5 | 9.2 | GO:0050654 | chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
1.5 | 4.6 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
1.5 | 32.0 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
1.5 | 7.5 | GO:0046836 | glycolipid transport(GO:0046836) |
1.5 | 6.0 | GO:0010999 | regulation of eIF2 alpha phosphorylation by heme(GO:0010999) |
1.5 | 5.9 | GO:0007616 | long-term memory(GO:0007616) |
1.5 | 32.4 | GO:0050890 | cognition(GO:0050890) |
1.5 | 47.0 | GO:0035082 | axoneme assembly(GO:0035082) |
1.5 | 5.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.5 | 4.4 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
1.4 | 4.3 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
1.4 | 4.3 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
1.4 | 4.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
1.4 | 1.4 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
1.4 | 104.0 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) |
1.4 | 4.1 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
1.4 | 51.8 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
1.4 | 8.1 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
1.4 | 6.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.3 | 21.4 | GO:0045778 | positive regulation of ossification(GO:0045778) |
1.3 | 9.3 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
1.3 | 2.6 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) |
1.3 | 5.3 | GO:0003334 | keratinocyte development(GO:0003334) |
1.3 | 16.8 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
1.3 | 5.2 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
1.3 | 3.8 | GO:0003266 | regulation of secondary heart field cardioblast proliferation(GO:0003266) |
1.3 | 1.3 | GO:0060278 | regulation of ovulation(GO:0060278) |
1.3 | 30.2 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
1.3 | 7.5 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
1.3 | 1.3 | GO:0042161 | lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) platelet activating factor metabolic process(GO:0046469) |
1.2 | 3.7 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
1.2 | 2.5 | GO:0070254 | mucus secretion(GO:0070254) |
1.2 | 1.2 | GO:0010044 | response to aluminum ion(GO:0010044) |
1.2 | 4.9 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.2 | 2.5 | GO:0048262 | determination of dorsal/ventral asymmetry(GO:0048262) |
1.2 | 1.2 | GO:0045837 | negative regulation of membrane potential(GO:0045837) |
1.2 | 2.4 | GO:0001826 | inner cell mass cell differentiation(GO:0001826) |
1.2 | 8.3 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
1.2 | 1.2 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
1.2 | 5.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
1.1 | 3.3 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
1.1 | 3.3 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.1 | 6.4 | GO:0010717 | regulation of epithelial to mesenchymal transition(GO:0010717) |
1.1 | 6.3 | GO:0048265 | response to pain(GO:0048265) |
1.0 | 31.4 | GO:0006112 | energy reserve metabolic process(GO:0006112) |
1.0 | 6.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) |
1.0 | 2.0 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
1.0 | 12.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
1.0 | 8.0 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
1.0 | 7.0 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
1.0 | 4.9 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
1.0 | 9.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.0 | 10.6 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.9 | 1.9 | GO:0071029 | polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.9 | 0.9 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) |
0.9 | 24.2 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.9 | 8.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.9 | 25.0 | GO:0043039 | tRNA aminoacylation for protein translation(GO:0006418) tRNA aminoacylation(GO:0043039) |
0.9 | 0.9 | GO:0010872 | regulation of cholesterol esterification(GO:0010872) |
0.9 | 1.8 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.9 | 2.6 | GO:1905208 | negative regulation of cardiocyte differentiation(GO:1905208) |
0.9 | 0.9 | GO:0001757 | somite specification(GO:0001757) |
0.9 | 1.7 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.9 | 9.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.9 | 4.3 | GO:0006821 | chloride transport(GO:0006821) |
0.9 | 4.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.8 | 11.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.8 | 0.8 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.8 | 0.8 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.8 | 4.1 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.8 | 2.5 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.8 | 2.5 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.8 | 18.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.8 | 4.8 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.8 | 2.4 | GO:2000178 | negative regulation of neural precursor cell proliferation(GO:2000178) |
0.8 | 3.2 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
0.8 | 4.6 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.8 | 1.5 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.8 | 2.3 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.8 | 7.7 | GO:0016926 | protein desumoylation(GO:0016926) |
0.8 | 0.8 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.8 | 0.8 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.7 | 1.5 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.7 | 1.5 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.7 | 15.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.7 | 1.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.7 | 5.7 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) |
0.7 | 4.9 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.7 | 6.1 | GO:0032456 | endocytic recycling(GO:0032456) |
0.7 | 161.8 | GO:0031175 | neuron projection development(GO:0031175) |
0.7 | 935.7 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.6 | 5.0 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.6 | 2.5 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.6 | 3.0 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.6 | 1.7 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.6 | 2.3 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.6 | 0.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.6 | 5.1 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.6 | 18.1 | GO:0099537 | trans-synaptic signaling(GO:0099537) |
0.5 | 34.1 | GO:0006457 | protein folding(GO:0006457) |
0.5 | 3.5 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.5 | 1.0 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
0.5 | 1.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.5 | 22.2 | GO:0001822 | kidney development(GO:0001822) |
0.5 | 1.4 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.5 | 0.5 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.5 | 1.4 | GO:0007320 | insemination(GO:0007320) |
0.5 | 3.7 | GO:0015886 | heme transport(GO:0015886) |
0.5 | 2.3 | GO:0001947 | heart looping(GO:0001947) |
0.5 | 0.5 | GO:0051665 | membrane raft localization(GO:0051665) |
0.4 | 1.8 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.4 | 1.8 | GO:0051875 | pigment granule localization(GO:0051875) |
0.4 | 3.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.4 | 0.4 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) GDP-L-fucose metabolic process(GO:0046368) |
0.4 | 3.8 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.4 | 0.4 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.4 | 2.5 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.4 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.4 | 0.8 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.4 | 4.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.4 | 1.2 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.4 | 0.4 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.4 | 5.9 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.4 | 0.7 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.3 | 0.3 | GO:0050955 | thermoception(GO:0050955) |
0.3 | 0.3 | GO:1905077 | regulation of interleukin-17 secretion(GO:1905076) negative regulation of interleukin-17 secretion(GO:1905077) |
0.3 | 0.3 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.3 | 1.3 | GO:0006885 | regulation of pH(GO:0006885) |
0.3 | 2.9 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.3 | 0.9 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.3 | 0.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.3 | 9.3 | GO:0016051 | carbohydrate biosynthetic process(GO:0016051) |
0.3 | 0.3 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.3 | 0.8 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.3 | 0.8 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
0.3 | 1.3 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.3 | 0.8 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.2 | 0.5 | GO:0009750 | response to fructose(GO:0009750) |
0.2 | 0.2 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.2 | 4.3 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.4 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.2 | 2.3 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.2 | 0.3 | GO:0010464 | regulation of mesenchymal cell proliferation(GO:0010464) |
0.2 | 0.2 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.1 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.1 | 0.3 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.1 | 0.4 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.1 | 0.1 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.1 | 0.1 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.1 | 0.3 | GO:0097354 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.1 | 0.2 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.1 | 0.9 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.1 | GO:0046078 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
0.0 | 0.0 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.0 | 0.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
92.0 | 92.0 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
66.2 | 198.7 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
49.8 | 199.1 | GO:0045298 | tubulin complex(GO:0045298) |
48.7 | 292.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
45.5 | 181.9 | GO:0097513 | myosin II filament(GO:0097513) |
42.3 | 127.0 | GO:0005960 | glycine cleavage complex(GO:0005960) |
42.1 | 126.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
40.6 | 162.3 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
40.3 | 161.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
39.0 | 116.9 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
37.6 | 150.4 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
33.5 | 67.0 | GO:0097444 | spine apparatus(GO:0097444) |
31.6 | 189.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
30.8 | 154.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
30.7 | 92.1 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
29.9 | 209.1 | GO:0043203 | axon hillock(GO:0043203) |
29.4 | 147.1 | GO:0098845 | postsynaptic endosome(GO:0098845) |
29.4 | 235.2 | GO:0005587 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
29.4 | 88.1 | GO:1990257 | piccolo-bassoon transport vesicle(GO:1990257) |
29.3 | 351.5 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
29.1 | 174.3 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
29.0 | 347.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
28.9 | 173.4 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
28.3 | 56.5 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
28.3 | 28.3 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
28.2 | 84.6 | GO:0005594 | collagen type IX trimer(GO:0005594) |
27.8 | 139.1 | GO:0044316 | cone cell pedicle(GO:0044316) |
27.8 | 83.3 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
27.6 | 82.8 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
27.3 | 628.1 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
26.9 | 350.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
26.8 | 80.5 | GO:0045242 | mitochondrial isocitrate dehydrogenase complex (NAD+)(GO:0005962) isocitrate dehydrogenase complex (NAD+)(GO:0045242) |
25.6 | 127.9 | GO:0005927 | muscle tendon junction(GO:0005927) |
25.1 | 100.4 | GO:0071914 | prominosome(GO:0071914) |
25.0 | 224.6 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
24.6 | 73.9 | GO:0014801 | longitudinal sarcoplasmic reticulum(GO:0014801) |
24.5 | 73.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
24.4 | 24.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
24.3 | 389.1 | GO:0005883 | neurofilament(GO:0005883) |
24.0 | 143.8 | GO:0033269 | internode region of axon(GO:0033269) |
23.5 | 94.0 | GO:0098831 | presynaptic active zone cytoplasmic component(GO:0098831) |
23.3 | 93.3 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
23.2 | 255.7 | GO:0032982 | myosin filament(GO:0032982) |
23.1 | 531.7 | GO:0033268 | node of Ranvier(GO:0033268) |
22.8 | 980.4 | GO:0048786 | presynaptic active zone(GO:0048786) |
22.7 | 68.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
21.9 | 87.5 | GO:0098888 | extrinsic component of presynaptic membrane(GO:0098888) |
21.8 | 305.4 | GO:0031045 | dense core granule(GO:0031045) |
21.5 | 214.7 | GO:0043083 | synaptic cleft(GO:0043083) |
21.0 | 105.2 | GO:0072534 | perineuronal net(GO:0072534) |
21.0 | 63.0 | GO:0098855 | HCN channel complex(GO:0098855) |
20.6 | 165.0 | GO:0044327 | dendritic spine head(GO:0044327) |
20.0 | 579.0 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
19.8 | 59.3 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
19.5 | 195.3 | GO:0044294 | dendritic growth cone(GO:0044294) |
18.9 | 75.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
18.6 | 74.4 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
18.6 | 93.0 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
18.1 | 108.8 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
18.0 | 71.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
17.8 | 106.5 | GO:0008091 | spectrin(GO:0008091) |
17.7 | 354.3 | GO:0030673 | axolemma(GO:0030673) |
17.1 | 137.1 | GO:0032584 | growth cone membrane(GO:0032584) |
16.7 | 150.4 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
16.4 | 147.3 | GO:0030314 | junctional membrane complex(GO:0030314) |
16.3 | 407.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
16.3 | 228.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
16.2 | 97.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
16.2 | 48.6 | GO:0045203 | intrinsic component of cell outer membrane(GO:0031230) integral component of cell outer membrane(GO:0045203) |
16.2 | 97.2 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
16.2 | 259.1 | GO:0034706 | sodium channel complex(GO:0034706) |
16.2 | 129.3 | GO:0005861 | troponin complex(GO:0005861) |
16.1 | 96.3 | GO:0032280 | symmetric synapse(GO:0032280) |
15.9 | 254.9 | GO:0097449 | astrocyte projection(GO:0097449) |
15.8 | 395.3 | GO:0031430 | M band(GO:0031430) |
15.1 | 45.4 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
14.9 | 44.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
14.9 | 14.9 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
14.8 | 44.4 | GO:1902560 | GMP reductase complex(GO:1902560) |
14.8 | 1301.6 | GO:0034705 | potassium channel complex(GO:0034705) |
14.7 | 600.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
14.5 | 741.3 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
14.4 | 14.4 | GO:0051286 | cell tip(GO:0051286) |
14.4 | 28.8 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
14.2 | 42.7 | GO:0043259 | laminin-10 complex(GO:0043259) |
13.7 | 178.7 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
13.6 | 122.3 | GO:0097470 | ribbon synapse(GO:0097470) |
13.4 | 53.5 | GO:0030139 | endocytic vesicle(GO:0030139) |
13.4 | 2257.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
13.3 | 159.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
13.3 | 119.6 | GO:0043194 | axon initial segment(GO:0043194) |
13.2 | 13.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
13.2 | 26.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
13.2 | 92.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
13.2 | 210.7 | GO:0016528 | sarcoplasm(GO:0016528) |
13.0 | 286.1 | GO:0044295 | axonal growth cone(GO:0044295) |
12.9 | 180.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
12.8 | 25.7 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
12.7 | 50.9 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
12.6 | 62.9 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
12.5 | 50.1 | GO:1990745 | EARP complex(GO:1990745) |
12.4 | 396.9 | GO:0097060 | synaptic membrane(GO:0097060) |
12.2 | 110.2 | GO:0005796 | Golgi lumen(GO:0005796) |
12.2 | 158.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
12.2 | 24.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
11.8 | 601.9 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
11.8 | 129.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
11.8 | 11.8 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
11.7 | 82.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
11.7 | 152.1 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
11.7 | 291.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
11.6 | 81.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
11.5 | 138.0 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
11.5 | 57.4 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
11.4 | 136.2 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
11.2 | 33.7 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
11.2 | 112.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
11.2 | 11.2 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
11.2 | 11.2 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
11.2 | 44.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
11.2 | 156.7 | GO:0032590 | dendrite membrane(GO:0032590) |
11.2 | 2023.3 | GO:0043209 | myelin sheath(GO:0043209) |
11.0 | 33.0 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
11.0 | 143.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
10.9 | 54.4 | GO:0048179 | activin receptor complex(GO:0048179) |
10.8 | 54.2 | GO:0070695 | FHF complex(GO:0070695) |
10.8 | 161.7 | GO:0045277 | respiratory chain complex IV(GO:0045277) |
10.8 | 32.3 | GO:0044308 | axonal spine(GO:0044308) |
10.7 | 935.2 | GO:0005604 | basement membrane(GO:0005604) |
10.7 | 214.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
10.7 | 32.2 | GO:0005955 | calcineurin complex(GO:0005955) |
10.7 | 438.5 | GO:0030315 | T-tubule(GO:0030315) |
10.6 | 295.7 | GO:0009925 | basal plasma membrane(GO:0009925) |
10.6 | 31.7 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
10.5 | 105.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
10.5 | 94.2 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
10.4 | 31.3 | GO:0060187 | cell pole(GO:0060187) |
10.4 | 41.5 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
10.2 | 71.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
10.2 | 71.2 | GO:0031143 | pseudopodium(GO:0031143) |
10.1 | 141.0 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
10.0 | 451.1 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
10.0 | 280.6 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
10.0 | 119.9 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
9.9 | 59.6 | GO:0043034 | costamere(GO:0043034) |
9.7 | 38.7 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
9.7 | 19.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
9.6 | 709.4 | GO:0031526 | brush border membrane(GO:0031526) |
9.3 | 55.7 | GO:0002141 | stereocilia ankle link(GO:0002141) |
9.3 | 55.6 | GO:0005787 | signal peptidase complex(GO:0005787) |
9.2 | 110.9 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
9.2 | 27.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
9.2 | 27.6 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
9.2 | 18.3 | GO:1990393 | 3M complex(GO:1990393) |
9.1 | 100.2 | GO:0043198 | dendritic shaft(GO:0043198) |
9.0 | 27.1 | GO:0045273 | respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) |
9.0 | 135.3 | GO:0097440 | apical dendrite(GO:0097440) |
9.0 | 856.7 | GO:0030427 | site of polarized growth(GO:0030427) |
9.0 | 62.9 | GO:0016600 | flotillin complex(GO:0016600) |
8.9 | 71.0 | GO:0000815 | ESCRT III complex(GO:0000815) |
8.7 | 43.7 | GO:0035976 | AP1 complex(GO:0035976) |
8.7 | 8.7 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
8.7 | 52.2 | GO:0012510 | trans-Golgi network transport vesicle membrane(GO:0012510) |
8.6 | 129.4 | GO:0071565 | nBAF complex(GO:0071565) |
8.5 | 25.6 | GO:0032433 | filopodium tip(GO:0032433) |
8.5 | 42.5 | GO:0097433 | dense body(GO:0097433) |
8.5 | 33.9 | GO:1990357 | terminal web(GO:1990357) |
8.5 | 228.7 | GO:0005921 | gap junction(GO:0005921) |
8.5 | 1870.3 | GO:0098794 | postsynapse(GO:0098794) |
8.4 | 58.7 | GO:0005916 | fascia adherens(GO:0005916) |
8.1 | 185.3 | GO:0043679 | axon terminus(GO:0043679) |
8.0 | 48.3 | GO:1990246 | uniplex complex(GO:1990246) |
8.0 | 48.2 | GO:0005915 | zonula adherens(GO:0005915) |
8.0 | 71.9 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
8.0 | 111.7 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
7.9 | 31.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
7.7 | 46.4 | GO:0005869 | dynactin complex(GO:0005869) |
7.7 | 23.2 | GO:0071942 | XPC complex(GO:0071942) |
7.7 | 7.7 | GO:1990836 | lysosomal matrix(GO:1990836) |
7.7 | 23.1 | GO:0033557 | Slx1-Slx4 complex(GO:0033557) |
7.6 | 38.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
7.5 | 7.5 | GO:1990130 | Iml1 complex(GO:1990130) |
7.5 | 45.1 | GO:0089701 | U2AF(GO:0089701) |
7.5 | 7.5 | GO:0016460 | myosin II complex(GO:0016460) |
7.4 | 14.8 | GO:0042583 | chromaffin granule(GO:0042583) |
7.3 | 264.4 | GO:0042383 | sarcolemma(GO:0042383) |
7.3 | 73.1 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
7.2 | 7.2 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
7.1 | 716.0 | GO:0030016 | myofibril(GO:0030016) |
7.1 | 21.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
7.0 | 49.2 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
7.0 | 84.0 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
7.0 | 20.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
6.9 | 20.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
6.9 | 41.6 | GO:0097443 | sorting endosome(GO:0097443) |
6.8 | 148.5 | GO:0055038 | recycling endosome membrane(GO:0055038) |
6.6 | 59.6 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
6.6 | 72.5 | GO:0072546 | ER membrane protein complex(GO:0072546) |
6.6 | 85.5 | GO:0045180 | basal cortex(GO:0045180) |
6.6 | 138.1 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
6.5 | 12.9 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
6.5 | 6.5 | GO:0000814 | ESCRT II complex(GO:0000814) |
6.4 | 1738.7 | GO:0045202 | synapse(GO:0045202) |
6.4 | 19.1 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
6.3 | 12.7 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
6.3 | 772.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
6.2 | 24.9 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
6.2 | 12.5 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
6.1 | 824.0 | GO:0016324 | apical plasma membrane(GO:0016324) |
6.1 | 614.7 | GO:0043296 | apical junction complex(GO:0043296) |
6.1 | 12.2 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
6.0 | 65.8 | GO:0005614 | interstitial matrix(GO:0005614) |
6.0 | 47.6 | GO:0042599 | lamellar body(GO:0042599) |
5.9 | 11.8 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
5.9 | 134.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
5.8 | 297.4 | GO:0031902 | late endosome membrane(GO:0031902) |
5.8 | 57.6 | GO:0034464 | BBSome(GO:0034464) |
5.8 | 23.0 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
5.8 | 97.9 | GO:0005905 | clathrin-coated pit(GO:0005905) |
5.7 | 1580.3 | GO:0043025 | neuronal cell body(GO:0043025) |
5.6 | 16.8 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
5.5 | 22.0 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
5.4 | 141.0 | GO:0005902 | microvillus(GO:0005902) |
5.3 | 133.7 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
5.3 | 5.3 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
5.3 | 42.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
5.3 | 1057.1 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
5.2 | 15.5 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
5.2 | 10.3 | GO:0070069 | cytochrome complex(GO:0070069) |
5.2 | 15.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
5.1 | 15.4 | GO:0031309 | intrinsic component of nuclear outer membrane(GO:0031308) integral component of nuclear outer membrane(GO:0031309) |
5.1 | 25.6 | GO:0070469 | respiratory chain(GO:0070469) |
5.1 | 15.3 | GO:0016939 | kinesin II complex(GO:0016939) |
5.1 | 472.3 | GO:0030424 | axon(GO:0030424) |
5.0 | 295.2 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
5.0 | 30.0 | GO:0070382 | exocytic vesicle(GO:0070382) |
5.0 | 24.8 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
4.9 | 14.8 | GO:0071437 | invadopodium(GO:0071437) |
4.9 | 14.7 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
4.8 | 33.7 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
4.8 | 67.3 | GO:0036038 | MKS complex(GO:0036038) |
4.8 | 9.5 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
4.7 | 9.5 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
4.7 | 33.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
4.7 | 28.3 | GO:0030057 | desmosome(GO:0030057) |
4.7 | 83.7 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
4.6 | 73.8 | GO:0035869 | ciliary transition zone(GO:0035869) |
4.6 | 32.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
4.6 | 269.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
4.5 | 4.5 | GO:0036117 | hyaluranon cable(GO:0036117) |
4.5 | 27.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
4.4 | 260.3 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
4.4 | 39.6 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
4.4 | 43.9 | GO:0030008 | TRAPP complex(GO:0030008) |
4.4 | 35.1 | GO:0005638 | lamin filament(GO:0005638) |
4.4 | 35.0 | GO:0016272 | prefoldin complex(GO:0016272) |
4.3 | 17.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
4.3 | 17.3 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
4.3 | 12.9 | GO:0045025 | mitochondrial degradosome(GO:0045025) |
4.2 | 8.5 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
4.2 | 12.6 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
4.2 | 25.1 | GO:0060091 | kinocilium(GO:0060091) |
4.1 | 12.3 | GO:0030897 | HOPS complex(GO:0030897) |
4.1 | 352.6 | GO:0005802 | trans-Golgi network(GO:0005802) |
4.1 | 65.6 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
4.1 | 77.3 | GO:0034707 | chloride channel complex(GO:0034707) |
4.0 | 28.1 | GO:0042629 | mast cell granule(GO:0042629) |
4.0 | 64.2 | GO:0000145 | exocyst(GO:0000145) |
3.9 | 261.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
3.9 | 7.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
3.9 | 96.3 | GO:0001533 | cornified envelope(GO:0001533) |
3.8 | 11.4 | GO:0061574 | ASAP complex(GO:0061574) |
3.8 | 49.4 | GO:0097546 | ciliary base(GO:0097546) |
3.8 | 22.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
3.6 | 18.0 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
3.5 | 150.0 | GO:0055037 | recycling endosome(GO:0055037) |
3.5 | 221.7 | GO:0030133 | transport vesicle(GO:0030133) |
3.4 | 16.9 | GO:1903768 | sweet taste receptor complex(GO:1903767) taste receptor complex(GO:1903768) |
3.4 | 10.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
3.3 | 23.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
3.3 | 269.0 | GO:0030027 | lamellipodium(GO:0030027) |
3.3 | 23.0 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
3.3 | 6.5 | GO:0042827 | platelet dense granule(GO:0042827) |
3.2 | 22.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
3.2 | 9.7 | GO:1990879 | CST complex(GO:1990879) |
3.2 | 6.4 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
3.1 | 43.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
3.1 | 65.6 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
3.1 | 349.2 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
3.1 | 12.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
3.1 | 6.2 | GO:0045098 | type III intermediate filament(GO:0045098) |
3.1 | 182.6 | GO:0031225 | anchored component of membrane(GO:0031225) |
3.0 | 12.1 | GO:0032021 | NELF complex(GO:0032021) |
3.0 | 12.1 | GO:0034657 | GID complex(GO:0034657) |
3.0 | 21.2 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
3.0 | 24.2 | GO:0019866 | organelle inner membrane(GO:0019866) |
3.0 | 18.0 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
3.0 | 23.9 | GO:0042587 | glycogen granule(GO:0042587) |
3.0 | 68.1 | GO:0031901 | early endosome membrane(GO:0031901) |
3.0 | 50.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
2.9 | 26.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
2.9 | 716.9 | GO:0000139 | Golgi membrane(GO:0000139) |
2.9 | 11.7 | GO:0005903 | brush border(GO:0005903) |
2.9 | 14.5 | GO:0045335 | phagocytic vesicle(GO:0045335) |
2.9 | 40.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
2.9 | 2.9 | GO:0001651 | dense fibrillar component(GO:0001651) |
2.7 | 189.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
2.7 | 16.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
2.6 | 15.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
2.6 | 5.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
2.6 | 177.3 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
2.6 | 2.6 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
2.5 | 68.6 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
2.5 | 19.8 | GO:0001891 | phagocytic cup(GO:0001891) |
2.5 | 14.8 | GO:0070847 | core mediator complex(GO:0070847) |
2.4 | 2.4 | GO:0031226 | intrinsic component of plasma membrane(GO:0031226) |
2.4 | 16.5 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
2.3 | 198.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
2.3 | 11.7 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
2.3 | 6.9 | GO:0098800 | inner mitochondrial membrane protein complex(GO:0098800) |
2.1 | 29.1 | GO:0005770 | late endosome(GO:0005770) |
2.0 | 20.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
2.0 | 10.2 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
2.0 | 38.6 | GO:0005901 | caveola(GO:0005901) |
2.0 | 46.0 | GO:0005776 | autophagosome(GO:0005776) |
2.0 | 14.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
2.0 | 291.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
1.9 | 13.6 | GO:0016589 | NURF complex(GO:0016589) |
1.9 | 1.9 | GO:1990909 | Wnt signalosome(GO:1990909) |
1.9 | 811.9 | GO:0005794 | Golgi apparatus(GO:0005794) |
1.8 | 5.5 | GO:1990707 | subtelomeric heterochromatin(GO:1990421) nuclear subtelomeric heterochromatin(GO:1990707) |
1.8 | 32.1 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.8 | 268.0 | GO:0015629 | actin cytoskeleton(GO:0015629) |
1.7 | 6.9 | GO:0032044 | DSIF complex(GO:0032044) |
1.7 | 11.9 | GO:0030870 | Mre11 complex(GO:0030870) |
1.7 | 3.4 | GO:0030135 | coated vesicle(GO:0030135) |
1.7 | 8.3 | GO:0097361 | CIA complex(GO:0097361) |
1.6 | 11.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
1.6 | 6.6 | GO:0071797 | LUBAC complex(GO:0071797) |
1.6 | 40.7 | GO:0005774 | vacuolar membrane(GO:0005774) |
1.6 | 298.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
1.6 | 4.8 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
1.6 | 1.6 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
1.6 | 3.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.5 | 26.5 | GO:0031966 | mitochondrial membrane(GO:0031966) |
1.5 | 4.4 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
1.5 | 6611.6 | GO:0016021 | integral component of membrane(GO:0016021) |
1.4 | 29.6 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
1.4 | 15.3 | GO:0001726 | ruffle(GO:0001726) |
1.4 | 6.9 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.2 | 5.0 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
1.2 | 2.5 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
1.2 | 2.4 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
1.2 | 6.0 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.1 | 3.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
1.0 | 6.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.9 | 4.7 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.9 | 3.7 | GO:0070552 | BRISC complex(GO:0070552) |
0.8 | 16.7 | GO:0005811 | lipid particle(GO:0005811) |
0.8 | 3.1 | GO:0097196 | Shu complex(GO:0097196) |
0.8 | 231.3 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.8 | 465.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.7 | 2.9 | GO:0035363 | histone locus body(GO:0035363) |
0.7 | 11.4 | GO:0031256 | leading edge membrane(GO:0031256) |
0.7 | 2.0 | GO:1990826 | nucleoplasmic periphery of the nuclear pore complex(GO:1990826) |
0.6 | 2.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.5 | 16.3 | GO:0005769 | early endosome(GO:0005769) |
0.4 | 19.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.4 | 1.6 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.4 | 5.3 | GO:0032039 | integrator complex(GO:0032039) |
0.3 | 3.3 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.2 | 2.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.2 | 1.9 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.1 | 70.6 | GO:0005886 | plasma membrane(GO:0005886) |
0.1 | 0.6 | GO:0031931 | TORC1 complex(GO:0031931) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
65.3 | 261.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
57.3 | 229.0 | GO:0099609 | microtubule lateral binding(GO:0099609) |
49.8 | 149.5 | GO:1902379 | chemoattractant activity involved in axon guidance(GO:1902379) |
41.7 | 125.0 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
41.5 | 207.6 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
39.5 | 276.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
38.4 | 191.8 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
37.5 | 299.8 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
36.9 | 147.4 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
35.3 | 282.5 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
34.4 | 137.6 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
34.4 | 103.1 | GO:0035939 | microsatellite binding(GO:0035939) |
34.1 | 272.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
33.3 | 99.9 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
33.3 | 133.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
32.4 | 129.6 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
31.6 | 189.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
31.3 | 94.0 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
30.8 | 184.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
30.7 | 92.1 | GO:0004807 | triose-phosphate isomerase activity(GO:0004807) |
30.5 | 243.8 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
30.4 | 152.2 | GO:0031014 | troponin T binding(GO:0031014) |
29.8 | 89.4 | GO:0030172 | troponin C binding(GO:0030172) |
28.6 | 114.6 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
28.5 | 85.5 | GO:0016403 | dimethylargininase activity(GO:0016403) |
28.5 | 85.5 | GO:0005017 | platelet-derived growth factor-activated receptor activity(GO:0005017) |
28.5 | 142.4 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
28.2 | 338.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
27.8 | 55.6 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
27.5 | 275.0 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
27.2 | 81.7 | GO:0099529 | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential(GO:0099529) |
27.2 | 923.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
26.9 | 698.3 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
26.3 | 131.5 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
25.7 | 77.2 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
25.5 | 102.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
25.1 | 100.5 | GO:0008489 | UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity(GO:0008489) |
25.0 | 125.0 | GO:0051373 | FATZ binding(GO:0051373) |
25.0 | 74.9 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
24.8 | 74.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
24.7 | 173.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
24.7 | 172.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
24.2 | 169.4 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
24.1 | 241.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
23.8 | 71.3 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
23.5 | 70.5 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
23.4 | 70.3 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
23.3 | 69.8 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
23.3 | 93.1 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
23.2 | 23.2 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
23.0 | 69.0 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
22.3 | 89.0 | GO:0099510 | calcium ion binding involved in regulation of cytosolic calcium ion concentration(GO:0099510) |
22.2 | 310.7 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
22.2 | 243.7 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
22.0 | 88.0 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
21.8 | 109.2 | GO:0004985 | opioid receptor activity(GO:0004985) |
21.7 | 152.1 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
21.7 | 43.4 | GO:0004046 | aminoacylase activity(GO:0004046) |
21.4 | 256.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
21.0 | 126.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
20.9 | 83.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
20.9 | 125.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
20.9 | 62.6 | GO:0048495 | Roundabout binding(GO:0048495) |
20.8 | 83.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
20.7 | 103.6 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
20.7 | 144.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
20.6 | 267.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
20.3 | 40.5 | GO:0004385 | guanylate kinase activity(GO:0004385) |
20.0 | 100.1 | GO:0043532 | angiostatin binding(GO:0043532) |
20.0 | 99.8 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
19.9 | 39.8 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
19.9 | 158.8 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
19.6 | 58.9 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
19.6 | 78.5 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
19.5 | 58.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
19.5 | 136.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
19.5 | 97.3 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
19.2 | 115.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
18.9 | 132.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
18.8 | 93.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
18.7 | 56.2 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
18.6 | 111.9 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
18.6 | 167.7 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
18.6 | 129.9 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
18.5 | 37.1 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
18.5 | 55.4 | GO:0071886 | 1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding(GO:0071886) |
18.5 | 92.3 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
18.4 | 55.2 | GO:0004096 | catalase activity(GO:0004096) |
18.4 | 55.1 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
18.3 | 54.9 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
18.2 | 328.0 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
18.2 | 163.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
18.1 | 650.1 | GO:0001540 | beta-amyloid binding(GO:0001540) |
18.1 | 198.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
18.0 | 72.2 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
18.0 | 126.0 | GO:0015185 | gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
17.9 | 89.5 | GO:0015142 | tricarboxylic acid transmembrane transporter activity(GO:0015142) |
17.9 | 35.7 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
17.2 | 34.5 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
17.2 | 34.4 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
17.2 | 51.6 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
17.2 | 85.9 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
17.1 | 102.4 | GO:0045503 | dynein light chain binding(GO:0045503) |
16.9 | 50.8 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
16.8 | 33.6 | GO:0036004 | GAF domain binding(GO:0036004) |
16.7 | 100.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
16.7 | 50.1 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
16.6 | 16.6 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
16.5 | 65.8 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
16.4 | 49.3 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
16.4 | 164.1 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
16.2 | 275.9 | GO:0000146 | microfilament motor activity(GO:0000146) |
16.1 | 112.5 | GO:0097001 | ceramide binding(GO:0097001) |
15.9 | 286.3 | GO:0044548 | S100 protein binding(GO:0044548) |
15.9 | 301.7 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
15.8 | 174.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
15.8 | 110.4 | GO:0098988 | G-protein coupled glutamate receptor activity(GO:0098988) |
15.8 | 47.3 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
15.8 | 47.3 | GO:0001565 | phorbol ester receptor activity(GO:0001565) |
15.7 | 47.2 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
15.6 | 93.8 | GO:0005217 | intracellular ligand-gated ion channel activity(GO:0005217) |
15.6 | 234.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
15.6 | 46.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
15.3 | 61.2 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
15.3 | 168.0 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
15.2 | 60.8 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
15.2 | 121.5 | GO:0071253 | connexin binding(GO:0071253) |
15.1 | 45.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
15.0 | 44.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
14.9 | 44.8 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
14.9 | 89.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
14.9 | 89.4 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
14.9 | 178.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
14.8 | 207.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
14.8 | 44.4 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
14.7 | 44.0 | GO:0019807 | aspartoacylase activity(GO:0019807) |
14.6 | 161.1 | GO:0051378 | serotonin binding(GO:0051378) |
14.5 | 101.4 | GO:0015368 | calcium, potassium:sodium antiporter activity(GO:0008273) calcium:cation antiporter activity(GO:0015368) |
14.5 | 58.0 | GO:0016492 | G-protein coupled neurotensin receptor activity(GO:0016492) |
14.4 | 14.4 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
14.4 | 187.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
14.3 | 42.8 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
14.2 | 327.7 | GO:0031489 | myosin V binding(GO:0031489) |
14.1 | 42.4 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
14.0 | 112.1 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
14.0 | 41.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
14.0 | 55.9 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
13.9 | 791.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
13.9 | 83.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
13.8 | 96.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
13.8 | 69.0 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
13.7 | 54.8 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
13.6 | 54.6 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) corticotropin-releasing hormone receptor activity(GO:0043404) |
13.6 | 217.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
13.6 | 40.8 | GO:0004058 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
13.6 | 81.6 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
13.5 | 67.5 | GO:0016775 | protein histidine kinase activity(GO:0004673) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
13.5 | 40.4 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
13.5 | 269.2 | GO:1905030 | voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
13.4 | 80.5 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
13.4 | 656.7 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
13.4 | 200.6 | GO:0015026 | coreceptor activity(GO:0015026) |
13.4 | 494.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
13.3 | 106.3 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
13.3 | 198.8 | GO:0016594 | glycine binding(GO:0016594) |
13.1 | 39.4 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
13.1 | 118.2 | GO:1903136 | cuprous ion binding(GO:1903136) |
13.1 | 65.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
13.1 | 13.1 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
13.1 | 39.2 | GO:0097016 | L27 domain binding(GO:0097016) |
13.0 | 117.2 | GO:0045499 | chemorepellent activity(GO:0045499) |
13.0 | 52.0 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
13.0 | 39.0 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
13.0 | 207.6 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
12.9 | 51.6 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
12.9 | 115.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
12.8 | 371.2 | GO:0017147 | Wnt-protein binding(GO:0017147) |
12.8 | 38.3 | GO:0000827 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) |
12.7 | 571.4 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
12.7 | 63.3 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
12.5 | 324.1 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
12.4 | 37.2 | GO:0008396 | oxysterol 7-alpha-hydroxylase activity(GO:0008396) |
12.3 | 172.2 | GO:0015250 | water channel activity(GO:0015250) |
12.3 | 61.4 | GO:0005042 | netrin receptor activity(GO:0005042) |
12.2 | 121.8 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
12.0 | 36.1 | GO:0004359 | glutaminase activity(GO:0004359) |
12.0 | 48.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
11.9 | 35.8 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
11.9 | 47.5 | GO:0055100 | adiponectin binding(GO:0055100) |
11.9 | 23.7 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
11.7 | 128.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
11.7 | 70.3 | GO:0005283 | sodium:amino acid symporter activity(GO:0005283) |
11.7 | 117.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
11.7 | 46.7 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) calcium-induced calcium release activity(GO:0048763) |
11.7 | 23.3 | GO:0098603 | selenol Se-methyltransferase activity(GO:0098603) |
11.7 | 128.2 | GO:0004017 | adenylate kinase activity(GO:0004017) |
11.6 | 69.5 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
11.5 | 138.5 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
11.3 | 385.5 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
11.3 | 34.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
11.3 | 90.6 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
11.3 | 67.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
11.3 | 33.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
11.2 | 33.7 | GO:2001070 | starch binding(GO:2001070) |
11.2 | 134.5 | GO:0033691 | sialic acid binding(GO:0033691) |
11.2 | 33.6 | GO:0098879 | structural constituent of postsynaptic specialization(GO:0098879) structural constituent of postsynaptic density(GO:0098919) |
11.2 | 201.6 | GO:0035254 | glutamate receptor binding(GO:0035254) |
11.2 | 67.0 | GO:0004471 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
11.2 | 33.5 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
11.1 | 33.4 | GO:0004736 | pyruvate carboxylase activity(GO:0004736) |
11.1 | 298.4 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
11.0 | 43.8 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
10.9 | 32.8 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
10.9 | 98.1 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
10.9 | 21.7 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
10.8 | 216.8 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
10.8 | 21.6 | GO:0051425 | PTB domain binding(GO:0051425) |
10.7 | 85.7 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
10.7 | 42.8 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
10.6 | 42.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
10.6 | 10.6 | GO:0043559 | insulin binding(GO:0043559) |
10.6 | 329.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
10.5 | 31.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
10.5 | 42.1 | GO:0030553 | cGMP binding(GO:0030553) |
10.5 | 105.1 | GO:0008242 | omega peptidase activity(GO:0008242) |
10.5 | 83.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
10.4 | 41.7 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
10.4 | 41.5 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
10.4 | 72.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
10.4 | 31.1 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
10.4 | 41.4 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
10.3 | 41.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
10.3 | 31.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
10.3 | 144.6 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
10.3 | 20.6 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
10.2 | 61.5 | GO:0043199 | sulfate binding(GO:0043199) |
10.1 | 40.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
10.1 | 40.3 | GO:0000298 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
10.0 | 49.9 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
9.9 | 9.9 | GO:0005119 | smoothened binding(GO:0005119) |
9.9 | 69.4 | GO:0008430 | selenium binding(GO:0008430) |
9.9 | 118.9 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
9.9 | 98.6 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
9.8 | 29.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
9.7 | 155.7 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
9.7 | 58.1 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
9.7 | 48.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
9.6 | 28.9 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
9.6 | 38.5 | GO:0035276 | ethanol binding(GO:0035276) |
9.6 | 19.1 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
9.5 | 19.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
9.5 | 104.9 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
9.5 | 181.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
9.5 | 113.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
9.5 | 85.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
9.4 | 37.8 | GO:0031544 | peptidyl-proline 3-dioxygenase activity(GO:0031544) |
9.4 | 18.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
9.3 | 9.3 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
9.3 | 37.3 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
9.3 | 46.6 | GO:0008502 | melatonin receptor activity(GO:0008502) |
9.3 | 352.9 | GO:0030507 | spectrin binding(GO:0030507) |
9.3 | 46.3 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
9.2 | 27.7 | GO:0001849 | complement component C1q binding(GO:0001849) |
9.2 | 36.6 | GO:0070699 | type II activin receptor binding(GO:0070699) |
9.1 | 45.7 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
9.1 | 45.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
9.1 | 54.7 | GO:0016918 | retinal binding(GO:0016918) |
9.1 | 54.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
9.1 | 36.4 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
9.1 | 45.4 | GO:0070052 | collagen V binding(GO:0070052) |
9.0 | 488.4 | GO:0030276 | clathrin binding(GO:0030276) |
9.0 | 18.1 | GO:0070905 | serine binding(GO:0070905) |
9.0 | 27.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
9.0 | 117.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
9.0 | 45.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
9.0 | 215.9 | GO:0019894 | kinesin binding(GO:0019894) |
9.0 | 26.9 | GO:0008405 | arachidonic acid 11,12-epoxygenase activity(GO:0008405) |
9.0 | 143.4 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
8.9 | 196.9 | GO:0001968 | fibronectin binding(GO:0001968) |
8.9 | 26.7 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
8.9 | 8.9 | GO:0005163 | nerve growth factor receptor binding(GO:0005163) |
8.8 | 61.8 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
8.8 | 105.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
8.8 | 43.9 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
8.8 | 87.9 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
8.8 | 26.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
8.8 | 61.4 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
8.8 | 43.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
8.8 | 35.1 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
8.8 | 17.5 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
8.7 | 26.1 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
8.7 | 78.4 | GO:0015266 | protein channel activity(GO:0015266) |
8.7 | 87.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
8.6 | 51.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
8.6 | 51.4 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
8.5 | 17.0 | GO:0048185 | activin binding(GO:0048185) |
8.5 | 25.5 | GO:0001847 | opsonin receptor activity(GO:0001847) |
8.4 | 8.4 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
8.4 | 16.8 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
8.4 | 16.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
8.3 | 133.0 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
8.3 | 16.6 | GO:0016917 | GABA receptor activity(GO:0016917) |
8.3 | 132.8 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
8.3 | 240.3 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
8.3 | 58.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
8.3 | 90.8 | GO:0005243 | gap junction channel activity(GO:0005243) |
8.3 | 24.8 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
8.2 | 32.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
8.2 | 24.6 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
8.2 | 81.9 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
8.2 | 711.1 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
8.2 | 40.8 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
8.2 | 65.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
8.1 | 8.1 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
8.1 | 32.4 | GO:0043495 | protein anchor(GO:0043495) |
8.1 | 32.3 | GO:0045159 | myosin II binding(GO:0045159) |
8.1 | 234.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
8.0 | 16.1 | GO:0032564 | dATP binding(GO:0032564) |
8.0 | 24.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
8.0 | 24.0 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
8.0 | 31.9 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
8.0 | 55.7 | GO:0043426 | MRF binding(GO:0043426) |
7.9 | 47.7 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
7.9 | 55.5 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
7.9 | 133.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
7.8 | 23.5 | GO:0031714 | C5a anaphylatoxin chemotactic receptor binding(GO:0031714) |
7.8 | 62.7 | GO:0031432 | titin binding(GO:0031432) |
7.8 | 234.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
7.8 | 15.6 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
7.8 | 54.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
7.8 | 62.1 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
7.7 | 23.2 | GO:0070404 | NADH binding(GO:0070404) |
7.7 | 30.9 | GO:0036033 | mediator complex binding(GO:0036033) |
7.7 | 15.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
7.7 | 7.7 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
7.7 | 30.8 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
7.7 | 15.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
7.6 | 38.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
7.6 | 99.0 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
7.6 | 22.8 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
7.6 | 15.2 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
7.6 | 98.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
7.5 | 135.1 | GO:0030552 | cAMP binding(GO:0030552) |
7.5 | 37.5 | GO:0034056 | estrogen response element binding(GO:0034056) |
7.5 | 44.9 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
7.5 | 59.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
7.5 | 29.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
7.4 | 7.4 | GO:1990955 | G-rich single-stranded DNA binding(GO:1990955) |
7.4 | 525.9 | GO:0030165 | PDZ domain binding(GO:0030165) |
7.4 | 59.2 | GO:0042285 | xylosyltransferase activity(GO:0042285) |
7.4 | 22.1 | GO:0031720 | haptoglobin binding(GO:0031720) |
7.3 | 14.7 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) |
7.3 | 44.0 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
7.3 | 14.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
7.3 | 43.7 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
7.3 | 29.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
7.3 | 14.5 | GO:0070698 | type I activin receptor binding(GO:0070698) |
7.3 | 21.8 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
7.3 | 29.0 | GO:0032896 | palmitoyl-CoA 9-desaturase activity(GO:0032896) |
7.3 | 217.6 | GO:0030546 | receptor activator activity(GO:0030546) |
7.1 | 35.4 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
7.1 | 35.3 | GO:0004962 | endothelin receptor activity(GO:0004962) |
7.0 | 7.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
7.0 | 21.1 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
7.0 | 28.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
7.0 | 7.0 | GO:0097677 | STAT family protein binding(GO:0097677) |
7.0 | 20.9 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
7.0 | 27.8 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
6.9 | 337.7 | GO:0005518 | collagen binding(GO:0005518) |
6.8 | 20.5 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
6.8 | 20.4 | GO:0002046 | opsin binding(GO:0002046) |
6.8 | 27.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
6.8 | 81.4 | GO:0031005 | filamin binding(GO:0031005) |
6.8 | 67.6 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
6.8 | 47.3 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
6.7 | 121.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
6.7 | 13.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
6.7 | 33.5 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
6.7 | 40.1 | GO:0015189 | L-lysine transmembrane transporter activity(GO:0015189) |
6.7 | 60.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
6.6 | 53.1 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
6.6 | 19.9 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
6.6 | 52.6 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
6.6 | 19.7 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
6.6 | 98.6 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
6.6 | 137.9 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
6.6 | 26.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
6.5 | 19.6 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
6.5 | 143.8 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
6.5 | 71.9 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
6.5 | 19.5 | GO:0015389 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
6.5 | 25.9 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
6.5 | 6.5 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
6.5 | 96.9 | GO:0008307 | structural constituent of muscle(GO:0008307) |
6.4 | 186.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
6.4 | 25.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
6.4 | 140.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
6.4 | 51.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
6.3 | 19.0 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
6.3 | 31.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
6.3 | 69.0 | GO:0015216 | purine nucleotide transmembrane transporter activity(GO:0015216) |
6.2 | 37.5 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
6.2 | 31.1 | GO:0045545 | syndecan binding(GO:0045545) |
6.2 | 37.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
6.2 | 117.3 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
6.1 | 190.0 | GO:0046875 | ephrin receptor binding(GO:0046875) |
6.1 | 24.4 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
6.1 | 73.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
6.1 | 18.3 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
6.1 | 12.2 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
6.1 | 48.7 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
6.1 | 30.4 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
6.0 | 72.6 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
6.0 | 48.4 | GO:0050811 | GABA receptor binding(GO:0050811) |
6.0 | 120.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
6.0 | 24.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
6.0 | 53.8 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
5.9 | 17.8 | GO:0005272 | sodium channel activity(GO:0005272) |
5.9 | 17.8 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
5.9 | 130.0 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
5.9 | 17.6 | GO:0047635 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
5.9 | 105.5 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
5.8 | 93.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
5.8 | 134.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
5.8 | 34.8 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
5.8 | 57.7 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
5.8 | 40.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
5.8 | 28.8 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
5.7 | 34.5 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
5.7 | 23.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
5.7 | 11.4 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
5.6 | 90.1 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
5.6 | 67.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
5.6 | 28.1 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
5.6 | 22.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
5.6 | 56.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
5.6 | 11.2 | GO:0070061 | fructose binding(GO:0070061) |
5.6 | 299.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
5.5 | 132.8 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
5.5 | 5.5 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
5.5 | 11.0 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
5.5 | 93.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
5.5 | 32.8 | GO:0045502 | dynein binding(GO:0045502) |
5.4 | 21.7 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
5.4 | 27.2 | GO:0090555 | phosphatidylethanolamine-translocating ATPase activity(GO:0090555) |
5.4 | 59.5 | GO:0042562 | hormone binding(GO:0042562) |
5.4 | 10.8 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
5.4 | 43.2 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
5.4 | 32.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
5.4 | 5.4 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
5.4 | 139.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
5.4 | 96.5 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
5.4 | 5.4 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
5.3 | 37.4 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
5.3 | 138.6 | GO:0050840 | extracellular matrix binding(GO:0050840) |
5.3 | 15.9 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
5.3 | 21.2 | GO:0004903 | growth hormone receptor activity(GO:0004903) |
5.3 | 36.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
5.2 | 15.7 | GO:0046790 | virion binding(GO:0046790) |
5.2 | 10.5 | GO:0042806 | fucose binding(GO:0042806) |
5.2 | 89.0 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
5.2 | 78.4 | GO:0042165 | neurotransmitter binding(GO:0042165) |
5.2 | 78.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
5.2 | 41.6 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
5.2 | 31.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
5.2 | 10.3 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
5.2 | 20.6 | GO:0030957 | Tat protein binding(GO:0030957) |
5.1 | 51.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
5.1 | 10.3 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
5.1 | 15.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
5.1 | 40.8 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
5.1 | 66.2 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
5.1 | 106.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
5.1 | 25.3 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
5.0 | 20.1 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
5.0 | 30.1 | GO:0017040 | ceramidase activity(GO:0017040) |
5.0 | 15.0 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
5.0 | 2512.8 | GO:0005509 | calcium ion binding(GO:0005509) |
5.0 | 10.0 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
5.0 | 9.9 | GO:0015925 | galactosidase activity(GO:0015925) |
4.9 | 178.2 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
4.9 | 24.7 | GO:0071617 | lysophospholipid acyltransferase activity(GO:0071617) |
4.9 | 19.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
4.9 | 14.8 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
4.9 | 14.7 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
4.8 | 33.9 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
4.8 | 100.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
4.8 | 23.9 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
4.8 | 129.0 | GO:0015296 | anion:cation symporter activity(GO:0015296) |
4.7 | 37.9 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
4.7 | 18.8 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
4.7 | 980.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
4.7 | 28.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
4.7 | 9.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
4.7 | 42.0 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
4.7 | 14.0 | GO:0034512 | box C/D snoRNA binding(GO:0034512) |
4.7 | 228.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
4.6 | 18.6 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
4.6 | 204.3 | GO:0044325 | ion channel binding(GO:0044325) |
4.6 | 13.9 | GO:0004946 | bombesin receptor activity(GO:0004946) |
4.6 | 27.7 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
4.6 | 45.8 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
4.5 | 54.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
4.5 | 45.4 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
4.5 | 27.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
4.5 | 18.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
4.5 | 85.5 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
4.5 | 17.9 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
4.5 | 13.4 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
4.5 | 17.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
4.4 | 17.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
4.4 | 8.8 | GO:0048030 | disaccharide binding(GO:0048030) |
4.4 | 136.1 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
4.4 | 17.5 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
4.4 | 267.4 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
4.4 | 13.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
4.3 | 4.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
4.3 | 34.8 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
4.3 | 21.7 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
4.3 | 94.3 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
4.3 | 51.0 | GO:0070403 | NAD+ binding(GO:0070403) |
4.2 | 4.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
4.2 | 105.1 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
4.2 | 20.9 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
4.1 | 53.9 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
4.1 | 4.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
4.1 | 49.3 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
4.1 | 32.8 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
4.1 | 16.3 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
4.0 | 24.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
4.0 | 12.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
4.0 | 883.0 | GO:0015631 | tubulin binding(GO:0015631) |
4.0 | 4.0 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
4.0 | 19.9 | GO:0050693 | LBD domain binding(GO:0050693) |
4.0 | 11.9 | GO:0102390 | mycophenolic acid acyl-glucuronide esterase activity(GO:0102390) |
3.9 | 31.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
3.9 | 15.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
3.9 | 3.9 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
3.9 | 3.9 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
3.9 | 97.7 | GO:0032947 | protein complex scaffold(GO:0032947) |
3.9 | 11.7 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
3.9 | 19.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
3.9 | 34.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
3.8 | 38.4 | GO:0004331 | fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
3.8 | 41.8 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
3.8 | 3.8 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
3.8 | 18.9 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
3.8 | 26.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
3.7 | 15.0 | GO:0046923 | ER retention sequence binding(GO:0046923) |
3.7 | 37.4 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
3.7 | 298.7 | GO:0051015 | actin filament binding(GO:0051015) |
3.7 | 18.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
3.7 | 44.6 | GO:0004659 | prenyltransferase activity(GO:0004659) |
3.7 | 11.0 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
3.6 | 50.8 | GO:0051018 | protein kinase A binding(GO:0051018) |
3.6 | 10.9 | GO:0046870 | cadmium ion binding(GO:0046870) |
3.6 | 7.2 | GO:0004064 | arylesterase activity(GO:0004064) |
3.6 | 10.8 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
3.6 | 75.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
3.6 | 14.3 | GO:0031419 | cobalamin binding(GO:0031419) |
3.6 | 24.9 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
3.5 | 10.6 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
3.5 | 24.8 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
3.5 | 3.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
3.5 | 3.5 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
3.5 | 59.1 | GO:0019825 | oxygen binding(GO:0019825) |
3.5 | 86.9 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
3.5 | 10.4 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
3.4 | 10.3 | GO:1990239 | steroid hormone binding(GO:1990239) |
3.4 | 17.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
3.4 | 3.4 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
3.4 | 13.5 | GO:0089720 | caspase binding(GO:0089720) |
3.4 | 40.5 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
3.4 | 718.8 | GO:0003924 | GTPase activity(GO:0003924) |
3.3 | 9.9 | GO:0009384 | N-acylmannosamine kinase activity(GO:0009384) |
3.3 | 6.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
3.3 | 9.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
3.3 | 23.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
3.3 | 46.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
3.3 | 6.5 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
3.2 | 39.0 | GO:0010181 | FMN binding(GO:0010181) |
3.2 | 12.9 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
3.2 | 70.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
3.2 | 3.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
3.2 | 12.8 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
3.2 | 73.5 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
3.2 | 3.2 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
3.2 | 69.8 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
3.2 | 22.2 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
3.2 | 22.1 | GO:0035240 | dopamine binding(GO:0035240) |
3.1 | 3.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
3.1 | 37.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
3.1 | 6.2 | GO:0005326 | neurotransmitter transporter activity(GO:0005326) |
3.1 | 6.2 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
3.1 | 24.7 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
3.1 | 15.4 | GO:0016247 | channel regulator activity(GO:0016247) |
3.1 | 12.3 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
3.1 | 9.2 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
3.1 | 64.5 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
3.0 | 12.0 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
3.0 | 18.0 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
3.0 | 8.9 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
3.0 | 11.9 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
3.0 | 14.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
3.0 | 3.0 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
2.9 | 23.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
2.9 | 37.9 | GO:0008061 | chitin binding(GO:0008061) |
2.9 | 291.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
2.9 | 20.4 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
2.9 | 82.9 | GO:0005262 | calcium channel activity(GO:0005262) |
2.8 | 25.6 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
2.8 | 50.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
2.8 | 30.8 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
2.8 | 5.6 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
2.8 | 8.4 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
2.8 | 11.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
2.8 | 5.5 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
2.7 | 19.1 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
2.7 | 10.9 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
2.7 | 10.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
2.7 | 16.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
2.7 | 61.1 | GO:0009055 | electron carrier activity(GO:0009055) |
2.6 | 21.0 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
2.6 | 10.3 | GO:0047619 | acylcarnitine hydrolase activity(GO:0047619) |
2.6 | 74.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
2.6 | 12.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
2.6 | 7.7 | GO:0047522 | 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
2.5 | 42.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
2.5 | 5.0 | GO:0043394 | proteoglycan binding(GO:0043394) |
2.5 | 27.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
2.5 | 7.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
2.5 | 5.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
2.5 | 34.7 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
2.5 | 4.9 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
2.5 | 56.5 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
2.4 | 12.2 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
2.4 | 112.4 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
2.4 | 9.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
2.4 | 11.8 | GO:0030695 | GTPase regulator activity(GO:0030695) |
2.4 | 7.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
2.3 | 7.0 | GO:0004925 | prolactin receptor activity(GO:0004925) |
2.3 | 14.0 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
2.3 | 37.3 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
2.3 | 9.3 | GO:0008441 | 3'(2'),5'-bisphosphate nucleotidase activity(GO:0008441) |
2.3 | 7.0 | GO:0031249 | denatured protein binding(GO:0031249) |
2.3 | 6.9 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
2.3 | 38.8 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
2.3 | 6.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
2.3 | 6.8 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
2.3 | 6.8 | GO:0016405 | CoA-ligase activity(GO:0016405) |
2.3 | 9.0 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
2.3 | 9.0 | GO:0035514 | DNA demethylase activity(GO:0035514) |
2.2 | 6.7 | GO:0051870 | methotrexate binding(GO:0051870) |
2.2 | 11.1 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
2.2 | 8.9 | GO:0005542 | folic acid binding(GO:0005542) |
2.2 | 2.2 | GO:0047708 | biotinidase activity(GO:0047708) |
2.2 | 71.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
2.2 | 10.8 | GO:0039706 | co-receptor binding(GO:0039706) |
2.1 | 10.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
2.1 | 34.0 | GO:0042805 | actinin binding(GO:0042805) |
2.1 | 2.1 | GO:0070644 | vitamin D response element binding(GO:0070644) |
2.1 | 4.2 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
2.1 | 6.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
2.0 | 8.1 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
2.0 | 8.1 | GO:0002058 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) |
2.0 | 6.0 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
2.0 | 33.8 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
2.0 | 2.0 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
2.0 | 7.9 | GO:0036122 | BMP binding(GO:0036122) |
2.0 | 17.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
2.0 | 33.4 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
2.0 | 5.9 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
1.9 | 5.8 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
1.9 | 3.9 | GO:0016411 | acylglycerol O-acyltransferase activity(GO:0016411) |
1.9 | 5.8 | GO:0071209 | U7 snRNA binding(GO:0071209) |
1.9 | 3.8 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.9 | 13.4 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
1.9 | 3.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.9 | 21.0 | GO:0051287 | NAD binding(GO:0051287) |
1.9 | 5.6 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
1.8 | 18.4 | GO:0005123 | death receptor binding(GO:0005123) |
1.8 | 7.3 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
1.8 | 14.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
1.8 | 56.1 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
1.8 | 5.4 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
1.8 | 7.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.8 | 7.1 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
1.8 | 7.1 | GO:0031386 | protein tag(GO:0031386) |
1.7 | 1.7 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.7 | 5.2 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
1.7 | 69.4 | GO:0017137 | Rab GTPase binding(GO:0017137) |
1.7 | 1.7 | GO:0003696 | satellite DNA binding(GO:0003696) |
1.7 | 27.0 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
1.7 | 5.1 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
1.6 | 11.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.6 | 3.3 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
1.6 | 8.1 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.6 | 45.4 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
1.6 | 1.6 | GO:0043734 | DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
1.6 | 4.8 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.6 | 69.2 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
1.6 | 6.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
1.6 | 1.6 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
1.6 | 6.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
1.6 | 6.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.5 | 7.7 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
1.5 | 9.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.5 | 27.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.5 | 3.0 | GO:0070492 | oligosaccharide binding(GO:0070492) |
1.5 | 8.9 | GO:0015215 | nucleotide transmembrane transporter activity(GO:0015215) |
1.5 | 155.6 | GO:0008237 | metallopeptidase activity(GO:0008237) |
1.4 | 11.6 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
1.4 | 51.5 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
1.4 | 1.4 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
1.4 | 8.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
1.4 | 41.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
1.4 | 30.9 | GO:0004407 | histone deacetylase activity(GO:0004407) |
1.4 | 2.8 | GO:0002162 | dystroglycan binding(GO:0002162) |
1.4 | 4.2 | GO:0051183 | vitamin transporter activity(GO:0051183) |
1.3 | 26.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
1.3 | 1.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
1.3 | 10.4 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
1.3 | 3.8 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
1.2 | 9.9 | GO:0051400 | BH domain binding(GO:0051400) |
1.2 | 9.9 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
1.2 | 7.2 | GO:0016722 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions(GO:0016722) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
1.2 | 3.5 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity(GO:0000703) |
1.2 | 13.8 | GO:0005112 | Notch binding(GO:0005112) |
1.1 | 1.1 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
1.1 | 11.2 | GO:0005244 | voltage-gated ion channel activity(GO:0005244) voltage-gated channel activity(GO:0022832) |
1.1 | 1.1 | GO:0001605 | adrenomedullin receptor activity(GO:0001605) |
1.1 | 5.4 | GO:0008294 | calcium- and calmodulin-responsive adenylate cyclase activity(GO:0008294) |
1.1 | 4.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
1.1 | 50.6 | GO:0005178 | integrin binding(GO:0005178) |
1.1 | 29.7 | GO:0000149 | SNARE binding(GO:0000149) |
1.1 | 3.2 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
1.0 | 30.0 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
1.0 | 7.2 | GO:0019213 | deacetylase activity(GO:0019213) |
1.0 | 20.1 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
1.0 | 4.0 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
1.0 | 4.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.0 | 24.3 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
1.0 | 13.4 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.0 | 1.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.9 | 1.8 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.8 | 4.2 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.8 | 127.4 | GO:0008092 | cytoskeletal protein binding(GO:0008092) |
0.8 | 2.5 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.8 | 49.1 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.8 | 10.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.8 | 3.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.8 | 7.7 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
0.7 | 38.7 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.7 | 5.8 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.7 | 11.0 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.7 | 1015.3 | GO:0004930 | G-protein coupled receptor activity(GO:0004930) |
0.7 | 3.3 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.6 | 5.2 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.6 | 3.1 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.6 | 3.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.6 | 1.8 | GO:0031402 | sodium ion binding(GO:0031402) |
0.6 | 3.0 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.6 | 2.3 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.6 | 0.6 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.6 | 35.4 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.6 | 6.7 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.5 | 0.5 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.5 | 1.5 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.4 | 1.6 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.4 | 0.4 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.4 | 1.5 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.4 | 0.7 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.3 | 2.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 2.3 | GO:0019203 | carbohydrate phosphatase activity(GO:0019203) |
0.3 | 1.3 | GO:0016160 | amylase activity(GO:0016160) |
0.3 | 4.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.3 | 0.3 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.3 | 3.6 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.3 | 3.4 | GO:0016755 | transferase activity, transferring amino-acyl groups(GO:0016755) |
0.3 | 0.8 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 0.5 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.2 | 0.2 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.2 | 10.1 | GO:0008514 | organic anion transmembrane transporter activity(GO:0008514) |
0.2 | 1.7 | GO:0000182 | rDNA binding(GO:0000182) |
0.2 | 0.2 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.2 | 0.7 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) |
0.2 | 0.3 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.1 | 0.3 | GO:0017168 | 5-oxoprolinase (ATP-hydrolyzing) activity(GO:0017168) |
0.0 | 0.3 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.1 | GO:0070401 | NADP+ binding(GO:0070401) |
0.0 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
41.4 | 41.4 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
22.0 | 285.6 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
17.5 | 69.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
14.7 | 132.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
13.7 | 150.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
13.5 | 67.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
13.4 | 13.4 | PID IFNG PATHWAY | IFN-gamma pathway |
12.7 | 253.3 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
12.4 | 620.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
11.6 | 81.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
11.5 | 196.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
11.2 | 402.1 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
10.5 | 303.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
10.3 | 153.9 | PID EPHA FWDPATHWAY | EPHA forward signaling |
10.1 | 392.3 | PID RAS PATHWAY | Regulation of Ras family activation |
9.9 | 188.9 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
9.9 | 267.9 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
9.9 | 356.9 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
9.5 | 199.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
8.3 | 241.5 | PID REELIN PATHWAY | Reelin signaling pathway |
8.3 | 140.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
8.2 | 1468.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
7.9 | 149.7 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
7.7 | 178.0 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
7.7 | 193.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
7.6 | 1148.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
7.6 | 181.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
7.2 | 294.5 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
7.2 | 50.2 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
7.0 | 7.0 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
6.9 | 62.1 | ST G ALPHA S PATHWAY | G alpha s Pathway |
6.9 | 343.5 | PID BMP PATHWAY | BMP receptor signaling |
6.8 | 54.8 | PID S1P S1P2 PATHWAY | S1P2 pathway |
6.8 | 82.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
6.7 | 127.8 | PID ARF 3PATHWAY | Arf1 pathway |
6.5 | 175.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
6.3 | 195.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
6.3 | 81.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
6.1 | 146.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
5.9 | 76.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
5.7 | 215.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
5.6 | 208.5 | PID FGF PATHWAY | FGF signaling pathway |
5.6 | 173.4 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
5.5 | 77.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
5.4 | 16.2 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
5.4 | 58.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
5.3 | 90.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
4.9 | 112.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
4.8 | 247.9 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
4.8 | 118.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
4.7 | 65.9 | PID EPHB FWD PATHWAY | EPHB forward signaling |
4.6 | 304.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
4.5 | 4.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
4.5 | 72.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
4.4 | 128.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
4.3 | 8.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
4.3 | 38.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
4.2 | 92.5 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
4.0 | 68.0 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
3.9 | 98.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
3.9 | 227.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
3.8 | 105.9 | PID CONE PATHWAY | Visual signal transduction: Cones |
3.8 | 3.8 | ST ADRENERGIC | Adrenergic Pathway |
3.7 | 77.3 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
3.5 | 28.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
3.4 | 84.1 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
3.3 | 137.7 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
3.3 | 74.9 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
3.0 | 138.9 | PID LKB1 PATHWAY | LKB1 signaling events |
3.0 | 6.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
2.8 | 87.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
2.6 | 113.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
2.6 | 5.2 | ST GAQ PATHWAY | G alpha q Pathway |
2.5 | 2.5 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
2.4 | 67.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
2.4 | 2.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
2.2 | 78.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
2.2 | 6.6 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
2.1 | 18.6 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
2.0 | 24.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
2.0 | 6.0 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
1.9 | 426.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
1.9 | 5.7 | SIG CHEMOTAXIS | Genes related to chemotaxis |
1.9 | 26.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.8 | 24.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
1.7 | 67.3 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
1.7 | 15.2 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
1.2 | 8.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.1 | 2.3 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
1.0 | 5.2 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.0 | 3.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
1.0 | 23.3 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
1.0 | 13.4 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.9 | 12.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.8 | 12.1 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.8 | 6.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.7 | 7.2 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.6 | 10.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.5 | 14.7 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 3.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
35.3 | 599.8 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
29.1 | 407.7 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
28.0 | 251.7 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
27.6 | 496.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
24.3 | 73.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
23.3 | 326.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
22.9 | 342.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
22.6 | 135.4 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
20.2 | 705.9 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
20.1 | 382.6 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
20.1 | 201.2 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
20.0 | 20.0 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
18.5 | 463.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
18.5 | 111.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
17.8 | 658.0 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
17.8 | 692.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
17.5 | 701.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
17.5 | 192.7 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
17.3 | 225.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
16.7 | 66.9 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
16.5 | 297.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
16.2 | 48.6 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
16.1 | 112.8 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
16.0 | 192.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
15.9 | 143.4 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
15.9 | 15.9 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
15.8 | 205.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
15.4 | 753.7 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
15.4 | 245.7 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
15.3 | 367.9 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
15.2 | 411.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
15.1 | 572.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
14.8 | 103.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
13.5 | 242.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
13.2 | 211.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
13.1 | 118.3 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
13.1 | 209.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
12.6 | 176.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
12.3 | 37.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
12.1 | 24.1 | REACTOME PI 3K CASCADE | Genes involved in PI-3K cascade |
12.0 | 216.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
12.0 | 264.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
12.0 | 300.2 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
11.8 | 11.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
11.7 | 711.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
11.3 | 56.6 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
11.2 | 224.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
11.2 | 157.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
11.0 | 285.0 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
10.9 | 141.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
10.8 | 97.4 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
10.8 | 204.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
10.7 | 96.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
10.5 | 209.3 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
10.2 | 122.8 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
10.1 | 181.3 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
9.9 | 167.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
9.8 | 29.3 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
9.8 | 165.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
9.5 | 113.6 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
9.4 | 301.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
9.4 | 112.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
9.3 | 18.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
9.2 | 55.4 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
9.2 | 238.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
9.0 | 271.3 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
8.9 | 142.9 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
8.9 | 133.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
8.6 | 86.4 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
8.5 | 136.2 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
8.5 | 34.0 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
8.3 | 83.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
8.3 | 8.3 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
8.3 | 49.6 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
8.2 | 82.0 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
8.2 | 180.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
8.1 | 227.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
8.0 | 104.6 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
7.9 | 71.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
7.9 | 109.9 | REACTOME TRANSMISSION ACROSS CHEMICAL SYNAPSES | Genes involved in Transmission across Chemical Synapses |
7.8 | 62.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
7.5 | 82.5 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
7.4 | 95.9 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
7.3 | 154.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
7.3 | 146.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
6.8 | 225.6 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
6.8 | 27.3 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
6.8 | 88.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
6.8 | 87.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
6.7 | 522.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
6.7 | 33.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
6.6 | 584.0 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
6.5 | 111.1 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
6.5 | 104.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
6.5 | 12.9 | REACTOME NEURONAL SYSTEM | Genes involved in Neuronal System |
6.4 | 127.4 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
6.2 | 222.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
6.0 | 181.2 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
6.0 | 209.6 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
5.9 | 159.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
5.9 | 94.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
5.9 | 122.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
5.7 | 735.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
5.7 | 80.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
5.6 | 134.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
5.6 | 150.4 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
5.6 | 5.6 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
5.5 | 66.3 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
5.4 | 146.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
5.4 | 92.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
5.4 | 5.4 | REACTOME REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | Genes involved in Regulation of Glucokinase by Glucokinase Regulatory Protein |
5.3 | 53.5 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
5.2 | 130.2 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
5.2 | 140.4 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
5.0 | 30.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
5.0 | 79.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
4.8 | 96.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
4.7 | 80.5 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
4.6 | 60.4 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
4.6 | 55.0 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
4.5 | 50.0 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
4.5 | 53.7 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
4.4 | 13.2 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
4.3 | 4.3 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
4.2 | 99.8 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
4.1 | 74.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
4.0 | 72.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
3.9 | 31.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
3.8 | 42.3 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
3.8 | 42.1 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
3.7 | 59.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
3.7 | 41.2 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
3.7 | 14.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
3.6 | 143.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
3.6 | 142.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
3.6 | 39.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
3.5 | 69.0 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
3.4 | 85.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
3.3 | 55.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
3.2 | 211.0 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
3.2 | 44.7 | REACTOME SIGNALLING TO ERKS | Genes involved in Signalling to ERKs |
3.1 | 59.1 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
3.1 | 12.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
3.1 | 21.7 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
3.1 | 83.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
3.0 | 334.4 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
3.0 | 41.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
2.9 | 32.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
2.9 | 35.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
2.9 | 2.9 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
2.8 | 91.7 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
2.7 | 16.5 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
2.7 | 57.5 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
2.6 | 20.7 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
2.6 | 79.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
2.5 | 98.7 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
2.3 | 20.9 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
2.3 | 114.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
2.2 | 35.6 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
2.1 | 64.3 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
2.1 | 12.6 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
2.0 | 29.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
2.0 | 13.8 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
2.0 | 45.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.9 | 48.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
1.9 | 3.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.9 | 11.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
1.8 | 119.1 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
1.8 | 43.7 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
1.7 | 53.4 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
1.6 | 21.2 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.4 | 20.4 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
1.3 | 5.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.3 | 5.3 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
1.3 | 7.7 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.2 | 7.5 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
1.2 | 15.9 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
1.1 | 19.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
1.1 | 11.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
1.0 | 5.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
1.0 | 40.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.9 | 1.9 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.9 | 8.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.8 | 11.7 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.8 | 94.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.7 | 39.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.6 | 0.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.5 | 4.1 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.4 | 1.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 5.8 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.3 | 23.6 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.3 | 2.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.2 | 3.7 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.2 | 5.2 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.2 | 2.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.1 | 2.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 0.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |